Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 412 articles:
HTML format
Text format



Single Articles


    January 2017
  1. HUBER B, Schellenbacher C, Shafti-Keramat S, Jindra C, et al
    Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV).
    PLoS One. 2017;12:e0169533.
    PubMed     Text format     Abstract available


  2. REN ST, Zhang XM, Sun PF, Sun LJ, et al
    Intranasal Immunization Using Mannatide as a Novel Adjuvant for an Inactivated Influenza Vaccine and Its Adjuvant Effect Compared with MF59.
    PLoS One. 2017;12:e0169501.
    PubMed     Text format     Abstract available


  3. MCCOLLUM ED, Nambiar B, Deula R, Zadutsa B, et al
    Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Clinical and Hypoxemic Childhood Pneumonia over Three Years in Central Malawi: An Observational Study.
    PLoS One. 2017;12:e0168209.
    PubMed     Text format     Abstract available


  4. MARTORELLI L, Garbaccio S, Vilte DA, Albanese AA, et al
    Immune Response in Calves Vaccinated with Type Three Secretion System Antigens and Shiga Toxin 2B Subunit of Escherichia coli O157:H7.
    PLoS One. 2017;12:e0169422.
    PubMed     Text format     Abstract available


  5. SLIKE BM, Creegan M, Marovich M, Ngauy V, et al
    Humoral Immunity to Primary Smallpox Vaccination: Impact of Childhood versus Adult Immunization on Vaccinia Vector Vaccine Development in Military Populations.
    PLoS One. 2017;12:e0169247.
    PubMed     Text format     Abstract available


  6. SMETANA J, Chlibek R, Hanovcova I, Sosovickova R, et al
    Decreasing Seroprevalence of Measles Antibodies after Vaccination - Possible Gap in Measles Protection in Adults in the Czech Republic.
    PLoS One. 2017;12:e0170257.
    PubMed     Text format     Abstract available


  7. HE Y, Sultana I, Takeda K, Reed JL, et al
    Cutaneous Deficiency of Filaggrin and STAT3 Exacerbates Vaccinia Disease In Vivo.
    PLoS One. 2017;12:e0170070.
    PubMed     Text format     Abstract available


  8. LU D, Qiao Y, Brown NE, Wang J, et al
    Racial and Ethnic Disparities in Influenza Vaccination among Adults with Chronic Medical Conditions Vary by Age in the United States.
    PLoS One. 2017;12:e0169679.
    PubMed     Text format     Abstract available


  9. BAWANKULE R, Singh A, Kumar K, Shetye S, et al
    Does Measles Vaccination Reduce the Risk of Acute Respiratory Infection (ARI) and Diarrhea in Children: A Multi-Country Study?
    PLoS One. 2017;12:e0169713.
    PubMed     Text format     Abstract available


  10. LEE HJ, Lee JY, Park MH, Kim JY, et al
    Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced Diseases.
    PLoS One. 2017;12:e0169139.
    PubMed     Text format     Abstract available


  11. SERRANO M, Elguezabal N, Sevilla IA, Geijo MV, et al
    Tuberculosis Detection in Paratuberculosis Vaccinated Calves: New Alternatives against Interference.
    PLoS One. 2017;12:e0169735.
    PubMed     Text format     Abstract available


  12. DARVISHIAN M, Dijkstra F, van Doorn E, Bijlsma MJ, et al
    Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes.
    PLoS One. 2017;12:e0169528.
    PubMed     Text format     Abstract available


  13. FALKENHORST G, Remschmidt C, Harder T, Hummers-Pradier E, et al
    Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis.
    PLoS One. 2017;12:e0169368.
    PubMed     Text format     Abstract available


  14. WANG J, Su C, Liu R, Liu B, et al
    A Pre-Clinical Safety Evaluation of SBP (HBsAg-Binding Protein) Adjuvant for Hepatitis B Vaccine.
    PLoS One. 2017;12:e0170313.
    PubMed     Text format     Abstract available


  15. TOSTES RO, Rodrigues TC, da Silva JB, Schanoski AS, et al
    Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae.
    PLoS One. 2017;12:e0170157.
    PubMed     Text format     Abstract available


  16. PRAPHASIRI P, Ditsungneon D, Greenbaum A, Dawood FS, et al
    Do Thai Physicians Recommend Seasonal Influenza Vaccines to Pregnant Women? A Cross-Sectional Survey of Physicians' Perspectives and Practices in Thailand.
    PLoS One. 2017;12:e0169221.
    PubMed     Text format     Abstract available


  17. HOWARD LM, Hoek KL, Goll JB, Samir P, et al
    Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled Trial.
    PLoS One. 2017;12:e0167488.
    PubMed     Text format     Abstract available


  18. LI K, Wei G, Cao Y, Li D, et al
    The Identification and Distribution of Cattle XCR1 and XCL1 among Peripheral Blood Cells: New Insights into the Design of Dendritic Cells Targeted Veterinary Vaccine.
    PLoS One. 2017;12:e0170575.
    PubMed     Text format     Abstract available


  19. DE SERRES G, Skowronski DM, Ward BJ, Gardam M, et al
    Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement.
    PLoS One. 2017;12:e0163586.
    PubMed     Text format     Abstract available


  20. HAYWARD AC
    Influenza Vaccination of Healthcare Workers Is an Important Approach for Reducing Transmission of Influenza from Staff to Vulnerable Patients.
    PLoS One. 2017;12:e0169023.
    PubMed     Text format    


  21. SECORE S, Wang S, Doughtry J, Xie J, et al
    Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains.
    PLoS One. 2017;12:e0170640.
    PubMed     Text format     Abstract available


  22. SCHMID P, Rauber D, Betsch C, Lidolt G, et al
    Barriers of Influenza Vaccination Intention and Behavior - A Systematic Review of Influenza Vaccine Hesitancy, 2005 - 2016.
    PLoS One. 2017;12:e0170550.
    PubMed     Text format     Abstract available


  23. HJALMARSDOTTIR MA, Quirk SJ, Haraldsson G, Erlendsdottir H, et al
    Comparison of Serotype Prevalence of Pneumococci Isolated from Middle Ear, Lower Respiratory Tract and Invasive Disease Prior to Vaccination in Iceland.
    PLoS One. 2017;12:e0169210.
    PubMed     Text format     Abstract available


  24. GORMLEY E, Ni Bhuachalla D, O'Keeffe J, Murphy D, et al
    Oral Vaccination of Free-Living Badgers (Meles meles) with Bacille Calmette Guerin (BCG) Vaccine Confers Protection against Tuberculosis.
    PLoS One. 2017;12:e0168851.
    PubMed     Text format     Abstract available


  25. MOISI JC, Makawa MS, Tall H, Agbenoko K, et al
    Burden of Pneumococcal Disease in Northern Togo before the Introduction of Pneumococcal Conjugate Vaccine.
    PLoS One. 2017;12:e0170412.
    PubMed     Text format     Abstract available


  26. MA L, Wang X, Bi X, Yang J, et al
    Characteristics Peripheral Blood IgG and IgM Heavy Chain Complementarity Determining Region 3 Repertoire before and after Immunization with Recombinant HBV Vaccine.
    PLoS One. 2017;12:e0170479.
    PubMed     Text format     Abstract available


  27. BURGHOUTS J, Del Nogal B, Uriepero A, Hermans PW, et al
    Childhood Vaccine Acceptance and Refusal among Warao Amerindian Caregivers in Venezuela; A Qualitative Approach.
    PLoS One. 2017;12:e0170227.
    PubMed     Text format     Abstract available


  28. FU Y, Li P, Cao Y, Wang N, et al
    Development of a Blocking ELISA Using a Monoclonal Antibody to a Dominant Epitope in Non-Structural Protein 3A of Foot-and-Mouth Disease Virus, as a Matching Test for a Negative-Marker Vaccine.
    PLoS One. 2017;12:e0170560.
    PubMed     Text format     Abstract available


  29. AIYEGBO MS, Shmelkov E, Dominguez L, Goger M, et al
    Peptide Targeted by Human Antibodies Associated with HIV Vaccine-Associated Protection Assumes a Dynamic alpha-Helical Structure.
    PLoS One. 2017;12:e0170530.
    PubMed     Text format     Abstract available


  30. ELAISH M, Ngunjiri JM, Ali A, Xia M, et al
    Supplementation of inactivated influenza vaccine with norovirus P particle-M2e chimeric vaccine enhances protection against heterologous virus challenge in chickens.
    PLoS One. 2017;12:e0171174.
    PubMed     Text format     Abstract available


  31. CILVETI R, Olmo M, Perez-Jove J, Picazo JJ, et al
    Epidemiology of Otitis Media with Spontaneous Perforation of the Tympanic Membrane in Young Children and Association with Bacterial Nasopharyngeal Carriage, Recurrences and Pneumococcal Vaccination in Catalonia, Spain - The Prospective HERMES Study.
    PLoS One. 2017;12:e0170316.
    PubMed     Text format     Abstract available


  32. ZHANG X, Mu Y, Mu P, Ao J, et al
    Transcriptome Analysis Reveals Comprehensive Insights into the Early Immune Response of Large Yellow Croaker (Larimichthys crocea) Induced by Trivalent Bacterial Vaccine.
    PLoS One. 2017;12:e0170958.
    PubMed     Text format     Abstract available


  33. ZHANG A, Lai H, Xu J, Huang W, et al
    Evaluation of the Protective Efficacy of Poly I:C as an Adjuvant for H9N2 Subtype Avian Influenza Inactivated Vaccine and Its Mechanism of Action in Ducks.
    PLoS One. 2017;12:e0170681.
    PubMed     Text format     Abstract available


  34. MARANA MH, Jorgensen LV, Skov J, Chettri JK, et al
    Subunit vaccine candidates against Aeromonas salmonicida in rainbow trout Oncorhynchus mykiss.
    PLoS One. 2017;12:e0171944.
    PubMed     Text format     Abstract available


  35. QU F, Weschler LB, Sun Y, Sundell J, et al
    High pneumonia lifetime-ever incidence in Beijing children compared with locations in other countries, and implications for national PCV and Hib vaccination.
    PLoS One. 2017;12:e0171438.
    PubMed     Text format     Abstract available


  36. OVSYANNIKOVA IG, Schaid DJ, Larrabee BR, Haralambieva IH, et al
    A large population-based association study between HLA and KIR genotypes and measles vaccine antibody responses.
    PLoS One. 2017;12:e0171261.
    PubMed     Text format     Abstract available


  37. PICAZO J, Ruiz-Contreras J, Casado-Flores J, Negreira S, et al
    Effect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive pneumococcal disease in children: Analysis of a hospital-based and population-based surveillance study in Madrid, Spain, 2007-2015.
    PLoS One. 2017;12:e0172222.
    PubMed     Text format     Abstract available


  38. GUTHRIE JL, Fisman D, Gardy JL
    Self-rated health and reasons for non-vaccination against seasonal influenza in Canadian adults with asthma.
    PLoS One. 2017;12:e0172117.
    PubMed     Text format     Abstract available


  39. ROJO JU, Melkus MW, Kottapalli KR, Okiya OE, et al
    Sm-p80-based schistosomiasis vaccine mediated epistatic interactions identified potential immune signatures for vaccine efficacy in mice and baboons.
    PLoS One. 2017;12:e0171677.
    PubMed     Text format     Abstract available


  40. MENG FY, Sun Y, Shen YG, Pan HF, et al
    Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China.
    PLoS One. 2017;12:e0172108.
    PubMed     Text format     Abstract available


  41. DE GROOT AS, Tounkara K, Rochas M, Beseme S, et al
    Knowledge, attitudes, practices and willingness to vaccinate in preparation for the introduction of HPV vaccines in Bamako, Mali.
    PLoS One. 2017;12:e0171631.
    PubMed     Text format     Abstract available


  42. DOMINGUEZ A, Soldevila N, Toledo D, Torner N, et al
    Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain.
    PLoS One. 2017;12:e0171943.
    PubMed     Text format     Abstract available


  43. HRADILOVA N, Sadilkova L, Palata O, Mysikova D, et al
    Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy.
    PLoS One. 2017;12:e0171539.
    PubMed     Text format     Abstract available


    January 2016
  44. CAUWELAERT ND, Desbien AL, Hudson TE, Pine SO, et al
    The TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for TH1 Induction.
    PLoS One. 2016;11:e0146372.
    PubMed     Text format     Abstract available


  45. HARMON TM, Fisher KA, McGlynn MG, Stover J, et al
    Exploring the Potential Health Impact and Cost-Effectiveness of AIDS Vaccine within a Comprehensive HIV/AIDS Response in Low- and Middle-Income Countries.
    PLoS One. 2016;11:e0146387.
    PubMed     Text format     Abstract available


  46. YU Y, Xu M, Sun J, Li R, et al
    Human Papillomavirus Infection and Vaccination: Awareness and Knowledge of HPV and Acceptability of HPV Vaccine among Mothers of Teenage Daughters in Weihai, Shandong, China.
    PLoS One. 2016;11:e0146741.
    PubMed     Text format     Abstract available


  47. FULLEN DJ, Noulin N, Catchpole A, Fathi H, et al
    Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.
    PLoS One. 2016;11:e0145902.
    PubMed     Text format     Abstract available


  48. WAUGH C, Khan SA, Carver S, Hanger J, et al
    A Prototype Recombinant-Protein Based Chlamydia pecorum Vaccine Results in Reduced Chlamydial Burden and Less Clinical Disease in Free-Ranging Koalas (Phascolarctos cinereus).
    PLoS One. 2016;11:e0146934.
    PubMed     Text format     Abstract available


  49. SELLENS E, Norris JM, Dhand NK, Heller J, et al
    Q Fever Knowledge, Attitudes and Vaccination Status of Australia's Veterinary Workforce in 2014.
    PLoS One. 2016;11:e0146819.
    PubMed     Text format     Abstract available


  50. KRISHNARAJAH G, Duh MS, Korves C, Demissie K, et al
    Public Health Impact of Complete and Incomplete Rotavirus Vaccination among Commercially and Medicaid Insured Children in the United States.
    PLoS One. 2016;11:e0145977.
    PubMed     Text format     Abstract available


  51. SINGH S, Vedi S, Samrat SK, Li W, et al
    Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines.
    PLoS One. 2016;11:e0146404.
    PubMed     Text format     Abstract available


  52. XIE E, Kotha A, Biaco T, Sedani N, et al
    Correction: Oral Delivery of a Novel Recombinant Streptococcus mitis Vector Elicits Robust Vaccine Antigen-Specific Oral Mucosal and Systemic Antibody Responses and T Cell Tolerance.
    PLoS One. 2016;11:e0147781.
    PubMed     Text format     Abstract available


  53. PRINS-VAN GINKEL AC, Berbers GA, Grundeken LH, Tcherniaeva I, et al
    Dynamics and Determinants of Pneumococcal Antibodies Specific against 13 Vaccine Serotypes in the Pre-Vaccination Era.
    PLoS One. 2016;11:e0147437.
    PubMed     Text format     Abstract available


  54. RODRIGUES-DA-SILVA RN, Martins da Silva JH, Singh B, Jiang J, et al
    In silico Identification and Validation of a Linear and Naturally Immunogenic B-Cell Epitope of the Plasmodium vivax Malaria Vaccine Candidate Merozoite Surface Protein-9.
    PLoS One. 2016;11:e0146951.
    PubMed     Text format     Abstract available


  55. LAKSHMINARAYANAN V, Supekar NT, Wei J, McCurry DB, et al
    MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice.
    PLoS One. 2016;11:e0145920.
    PubMed     Text format     Abstract available


  56. LAUGHLIN RC, Drake KL, Morrill JC, Adams LG, et al
    Correlative Gene Expression to Protective Seroconversion in Rift Valley Fever Vaccinates.
    PLoS One. 2016;11:e0147027.
    PubMed     Text format     Abstract available


  57. GANDHI K, Thera MA, Coulibaly D, Traore K, et al
    Correction: Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications.
    PLoS One. 2016;11:e0148240.
    PubMed     Text format     Abstract available


  58. MANCINI F, Monaci E, Lofano G, Torre A, et al
    One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A.
    PLoS One. 2016;11:e0147767.
    PubMed     Text format     Abstract available


  59. ZHU S, Zhang C, Wang J, Wei L, et al
    Immunity Elicited by an Experimental Vaccine Based on Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein in Piglets.
    PLoS One. 2016;11:e0147432.
    PubMed     Text format     Abstract available


  60. LIAO Z, Tang H, Xu X, Liang Y, et al
    Immunogenicity and Safety of Influenza Vaccination in Systemic Lupus Erythematosus Patients Compared with Healthy Controls: A Meta-Analysis.
    PLoS One. 2016;11:e0147856.
    PubMed     Text format     Abstract available


  61. RADY HF, Dai G, Huang W, Shellito JE, et al
    Flagellin Encoded in Gene-Based Vector Vaccines Is a Route-Dependent Immune Adjuvant.
    PLoS One. 2016;11:e0148701.
    PubMed     Text format     Abstract available


  62. MCGILL JL, Nair AD, Cheng C, Rusk RA, et al
    Vaccination with an Attenuated Mutant of Ehrlichia chaffeensis Induces Pathogen-Specific CD4+ T Cell Immunity and Protection from Tick-Transmitted Wild-Type Challenge in the Canine Host.
    PLoS One. 2016;11:e0148229.
    PubMed     Text format     Abstract available


  63. WANLAPAKORN N, Ngaovithunvong V, Thongmee T, Vichaiwattana P, et al
    Seroprevalence of Antibodies to Pertussis Toxin among Different Age Groups in Thailand after 37 Years of Universal Whole-Cell Pertussis Vaccination.
    PLoS One. 2016;11:e0148338.
    PubMed     Text format     Abstract available


  64. NABER SK, Matthijsse SM, Rozemeijer K, Penning C, et al
    Cervical Cancer Screening in Partly HPV Vaccinated Cohorts - A Cost-Effectiveness Analysis.
    PLoS One. 2016;11:e0145548.
    PubMed     Text format     Abstract available


  65. DOMINIAK-FELDEN G, Gobbo C, Simondon F
    Correction: Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study.
    PLoS One. 2016;11:e0148665.
    PubMed     Text format     Abstract available


  66. DOMINGUEZ A, Soldevila N, Toledo D, Godoy P, et al
    Factors Associated with Influenza Vaccination of Hospitalized Elderly Patients in Spain.
    PLoS One. 2016;11:e0147931.
    PubMed     Text format     Abstract available


  67. FIORE-GARTLAND A, Manso BA, Friedrich DP, Gabriel EE, et al
    Pooled-Peptide Epitope Mapping Strategies Are Efficient and Highly Sensitive: An Evaluation of Methods for Identifying Human T Cell Epitope Specificities in Large-Scale HIV Vaccine Efficacy Trials.
    PLoS One. 2016;11:e0147812.
    PubMed     Text format     Abstract available


  68. ASATI A, Kachurina O, Karol A, Dhir V, et al
    Fluorescence Adherence Inhibition Assay: A Novel Functional Assessment of Blocking Virus Attachment by Vaccine-Induced Antibodies.
    PLoS One. 2016;11:e0144261.
    PubMed     Text format     Abstract available


  69. SWART EM, van Gageldonk PG, de Melker HE, van der Klis FR, et al
    Long-Term Protection against Diphtheria in the Netherlands after 50 Years of Vaccination: Results from a Seroepidemiological Study.
    PLoS One. 2016;11:e0148605.
    PubMed     Text format     Abstract available


  70. MEIRING S, Cohen C, Quan V, de Gouveia L, et al
    HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV).
    PLoS One. 2016;11:e0149104.
    PubMed     Text format     Abstract available


  71. MCKAY PF, King DF, Mann JF, Barinaga G, et al
    TLR4 and TLR7/8 Adjuvant Combinations Generate Different Vaccine Antigen-Specific Immune Outcomes in Minipigs when Administered via the ID or IN Routes.
    PLoS One. 2016;11:e0148984.
    PubMed     Text format     Abstract available


  72. ENGELMANN F, Rivera A, Park B, Messerle-Forbes M, et al
    Impact of Estrogen Therapy on Lymphocyte Homeostasis and the Response to Seasonal Influenza Vaccine in Post-Menopausal Women.
    PLoS One. 2016;11:e0149045.
    PubMed     Text format     Abstract available


  73. PICCIRILLO A, Lavezzo E, Niero G, Moreno A, et al
    Full Genome Sequence-Based Comparative Study of Wild-Type and Vaccine Strains of Infectious Laryngotracheitis Virus from Italy.
    PLoS One. 2016;11:e0149529.
    PubMed     Text format     Abstract available


  74. GUERRA-PEREZ N, Aravantinou M, Veglia F, Goode D, et al
    Rectal HSV-2 Infection May Increase Rectal SIV Acquisition Even in the Context of SIVDeltanef Vaccination.
    PLoS One. 2016;11:e0149491.
    PubMed     Text format     Abstract available


  75. KIM NS, Mbongue JC, Nicholas DA, Esebanmen GE, et al
    Chimeric Vaccine Stimulation of Human Dendritic Cell Indoleamine 2, 3-Dioxygenase Occurs via the Non-Canonical NF-kappaB Pathway.
    PLoS One. 2016;11:e0147509.
    PubMed     Text format     Abstract available


  76. XIAO M, Zhao R, Zhang Q, Fan X, et al
    Genotypic Diversity of Staphylococcus aureus alpha-Hemolysin Gene (hla) and Its Association with Clonal Background: Implications for Vaccine Development.
    PLoS One. 2016;11:e0149112.
    PubMed     Text format     Abstract available


  77. VAN HOEVEN N, Joshi SW, Nana GI, Bosco-Lauth A, et al
    A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations.
    PLoS One. 2016;11:e0149610.
    PubMed     Text format     Abstract available


  78. LI LL, Wang HR, Zhou ZY, Luo J, et al
    C3-Luc Cells Are an Excellent Model for Evaluation of Cellular Immunity following HPV16L1 Vaccination.
    PLoS One. 2016;11:e0149748.
    PubMed     Text format     Abstract available


  79. YANG HJ, Zhang JY, Wei C, Yang LY, et al
    Immunisation With Immunodominant Linear B Cell Epitopes Vaccine of Manganese Transport Protein C Confers Protection against Staphylococcus aureus Infection.
    PLoS One. 2016;11:e0149638.
    PubMed     Text format     Abstract available


  80. MESEDA CA, Atukorale V, Kuhn J, Schmeisser F, et al
    Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines.
    PLoS One. 2016;11:e0149364.
    PubMed     Text format     Abstract available


  81. XIE B, Zhang P, Liu M, Zeng W, et al
    Deltex1 Polymorphisms Are Associated with Hepatitis B Vaccination Non-Response in Southwest China.
    PLoS One. 2016;11:e0149199.
    PubMed     Text format     Abstract available


  82. FENG X, Ma JW, Sun SQ, Guo HC, et al
    Quantitative Detection of the Foot-And-Mouth Disease Virus Serotype O 146S Antigen for Vaccine Production Using a Double-Antibody Sandwich ELISA and Nonlinear Standard Curves.
    PLoS One. 2016;11:e0149569.
    PubMed     Text format     Abstract available


  83. HIGUCHI A, Toriniwa H, Komiya T, Nakayama T, et al
    Recombinant Measles AIK-C Vaccine Strain Expressing the prM-E Antigen of Japanese Encephalitis Virus.
    PLoS One. 2016;11:e0150213.
    PubMed     Text format     Abstract available


  84. MCCAIG WD, Loving CL, Hughes HR, Brockmeier SL, et al
    Characterization and Vaccine Potential of Outer Membrane Vesicles Produced by Haemophilus parasuis.
    PLoS One. 2016;11:e0149132.
    PubMed     Text format     Abstract available


  85. IYER AS, Khaskhely NM, Leggat DJ, Ohtola JA, et al
    Inflammatory Markers and Immune Response to Pneumococcal Vaccination in HIV-Positive and -Negative Adults.
    PLoS One. 2016;11:e0150261.
    PubMed     Text format     Abstract available


  86. SONG L, Xiong D, Hu M, Kang X, et al
    Immunopotentiation of Different Adjuvants on Humoral and Cellular Immune Responses Induced by HA1-2 Subunit Vaccines of H7N9 Influenza in Mice.
    PLoS One. 2016;11:e0150678.
    PubMed     Text format     Abstract available


  87. FRAHM GE, Pochopsky AW, Clarke TM, Johnston MJ, et al
    Evaluation of Microflow Digital Imaging Particle Analysis for Sub-Visible Particles Formulated with an Opaque Vaccine Adjuvant.
    PLoS One. 2016;11:e0150229.
    PubMed     Text format     Abstract available


  88. VALERO-PACHECO N, Perez-Toledo M, Villasis-Keever MA, Nunez-Valencia A, et al
    Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine.
    PLoS One. 2016;11:e0150146.
    PubMed     Text format     Abstract available


  89. VONASEK BJ, Bajunirwe F, Jacobson LE, Twesigye L, et al
    Do Maternal Knowledge and Attitudes towards Childhood Immunizations in Rural Uganda Correlate with Complete Childhood Vaccination?
    PLoS One. 2016;11:e0150131.
    PubMed     Text format     Abstract available


  90. VAN HOEK AJ, Miller E
    Cost-Effectiveness of Vaccinating Immunocompetent >/=65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England.
    PLoS One. 2016;11:e0149540.
    PubMed     Text format     Abstract available


  91. KON TC, Onu A, Berbecila L, Lupulescu E, et al
    Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes.
    PLoS One. 2016;11:e0150700.
    PubMed     Text format     Abstract available


  92. JURCHOTT K, Schulz AR, Bozzetti C, Pohlmann D, et al
    Highly Predictive Model for a Protective Immune Response to the A(H1N1)pdm2009 Influenza Strain after Seasonal Vaccination.
    PLoS One. 2016;11:e0150812.
    PubMed     Text format     Abstract available


  93. TASANIYANANDA N, Chaisri U, Tungtrongchitr A, Chaicumpa W, et al
    Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine.
    PLoS One. 2016;11:e0150463.
    PubMed     Text format     Abstract available


  94. LEINO T, Ollgren J, Stromberg N, Elonsalo U, et al
    Evaluation of the Intussusception Risk after Pentavalent Rotavirus Vaccination in Finnish Infants.
    PLoS One. 2016;11:e0144812.
    PubMed     Text format     Abstract available


  95. JONES DS, Rowe CG, Chen B, Reiter K, et al
    A Method for Producing Protein Nanoparticles with Applications in Vaccines.
    PLoS One. 2016;11:e0138761.
    PubMed     Text format     Abstract available


  96. ABAD R, Medina V, Stella M, Boccadifuoco G, et al
    Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences with Other European Countries.
    PLoS One. 2016;11:e0150721.
    PubMed     Text format     Abstract available


  97. RAMIREZ A, Co M, Mathew A
    CpG Improves Influenza Vaccine Efficacy in Young Adult but Not Aged Mice.
    PLoS One. 2016;11:e0150425.
    PubMed     Text format     Abstract available


  98. MIZRACHI NEBENZAHL Y, Blau K, Kushnir T, Shagan M, et al
    Streptococcus pneumoniae Cell-Wall-Localized Phosphoenolpyruvate Protein Phosphotransferase Can Function as an Adhesin: Identification of Its Host Target Molecules and Evaluation of Its Potential as a Vaccine.
    PLoS One. 2016;11:e0150320.
    PubMed     Text format     Abstract available


  99. WIETEN RW, Jonker EF, van Leeuwen EM, Remmerswaal EB, et al
    A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination.
    PLoS One. 2016;11:e0149871.
    PubMed     Text format     Abstract available


  100. REDLBERGER-FRITZ M, Kundi M, Popow-Kraupp T
    Detailed Report on 2014/15 Influenza Virus Characteristics, and Estimates on Influenza Virus Vaccine Effectiveness from Austria's Sentinel Physician Surveillance Network.
    PLoS One. 2016;11:e0149916.
    PubMed     Text format     Abstract available


  101. REHN M, Uhnoo I, Kuhlmann-Berenzon S, Wallensten A, et al
    Highest Vaccine Uptake after School-Based Delivery - A County-Level Evaluation of the Implementation Strategies for HPV Catch-Up Vaccination in Sweden.
    PLoS One. 2016;11:e0149857.
    PubMed     Text format     Abstract available


  102. CHILENGI R, Simuyandi M, Beach L, Mwila K, et al
    Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants.
    PLoS One. 2016;11:e0150100.
    PubMed     Text format     Abstract available


  103. PENG X, Li SS, Gilbert PB, Geraghty DE, et al
    FCGR2C Polymorphisms Associated with HIV-1 Vaccine Protection Are Linked to Altered Gene Expression of Fc-gamma Receptors in Human B Cells.
    PLoS One. 2016;11:e0152425.
    PubMed     Text format     Abstract available


  104. HOMOLKA S, Ubben T, Niemann S
    High Sequence Variability of the ppE18 Gene of Clinical Mycobacterium tuberculosis Complex Strains Potentially Impacts Effectivity of Vaccine Candidate M72/AS01E.
    PLoS One. 2016;11:e0152200.
    PubMed     Text format     Abstract available


  105. VAN EFFELTERRE T, Dos Santos G, Shinde V
    Twin Peaks: A/H1N1 Pandemic Influenza Virus Infection and Vaccination in Norway, 2009-2010.
    PLoS One. 2016;11:e0151575.
    PubMed     Text format     Abstract available


  106. GILES C, Ndi O, Barton MD, Vanniasinkam T, et al
    An Adenoviral Vector Based Vaccine for Rhodococcus equi.
    PLoS One. 2016;11:e0152149.
    PubMed     Text format     Abstract available


  107. GOVINDARAJAN D, Guan L, Meschino S, Fridman A, et al
    A Rapid and Improved Method to Generate Recombinant Dengue Virus Vaccine Candidates.
    PLoS One. 2016;11:e0152209.
    PubMed     Text format     Abstract available


  108. LAWS TR, Kuchuloria T, Chitadze N, Little SF, et al
    A Comparison of the Adaptive Immune Response between Recovered Anthrax Patients and Individuals Receiving Three Different Anthrax Vaccines.
    PLoS One. 2016;11:e0148713.
    PubMed     Text format     Abstract available


  109. ZIMMERMANN MT, Oberg AL, Grill DE, Ovsyannikova IG, et al
    System-Wide Associations between DNA-Methylation, Gene Expression, and Humoral Immune Response to Influenza Vaccination.
    PLoS One. 2016;11:e0152034.
    PubMed     Text format     Abstract available


  110. CAINI S, Andrade W, Badur S, Balmaseda A, et al
    Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination?
    PLoS One. 2016;11:e0152310.
    PubMed     Text format     Abstract available


  111. BELICHENKO PV, Madani R, Rey-Bellet L, Pihlgren M, et al
    An Anti-beta-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome.
    PLoS One. 2016;11:e0152471.
    PubMed     Text format     Abstract available


  112. CASSEMIRO KM, Burlandy FM, Barbosa MR, Chen Q, et al
    Molecular and Phenotypic Characterization of a Highly Evolved Type 2 Vaccine-Derived Poliovirus Isolated from Seawater in Brazil, 2014.
    PLoS One. 2016;11:e0152251.
    PubMed     Text format     Abstract available


  113. DIAZ J, Terrazas S, Bierrenbach AL, Toscano CM, et al
    Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine (PCV-10) in Children in Chile: A Nested Case-Control Study Using Nationwide Pneumonia Morbidity and Mortality Surveillance Data.
    PLoS One. 2016;11:e0153141.
    PubMed     Text format     Abstract available


  114. GARCIA M, Misplon JA, Price GE, Lo CY, et al
    Age Dependence of Immunity Induced by a Candidate Universal Influenza Vaccine in Mice.
    PLoS One. 2016;11:e0153195.
    PubMed     Text format     Abstract available


  115. SEPULVEDA D, Lorenzen N
    Can VHS Virus Bypass the Protective Immunity Induced by DNA Vaccination in Rainbow Trout?
    PLoS One. 2016;11:e0153306.
    PubMed     Text format     Abstract available


  116. NGUYEN C, Carlson JM
    Optimizing Real-Time Vaccine Allocation in a Stochastic SIR Model.
    PLoS One. 2016;11:e0152950.
    PubMed     Text format     Abstract available


  117. SIMMONS M, Sun P, Putnak R
    Recombinant Dengue 2 Virus NS3 Helicase Protein Enhances Antibody and T-Cell Response of Purified Inactivated Vaccine.
    PLoS One. 2016;11:e0152811.
    PubMed     Text format     Abstract available


  118. SHAO J, Gao F, Lin HJ, Mao QY, et al
    Short-Fragment DNA Residue from Vaccine Purification Processes Promotes Immune Response to the New Inactivated EV71 Vaccine by Upregulating TLR9 mRNA.
    PLoS One. 2016;11:e0153867.
    PubMed     Text format     Abstract available


  119. MOR V, Farnoud AM, Singh A, Rella A, et al
    Glucosylceramide Administration as a Vaccination Strategy in Mouse Models of Cryptococcosis.
    PLoS One. 2016;11:e0153853.
    PubMed     Text format     Abstract available


  120. STONE BC, Kas A, Billman ZP, Fuller DH, et al
    Complex Minigene Library Vaccination for Discovery of Pre-Erythrocytic Plasmodium T Cell Antigens.
    PLoS One. 2016;11:e0153449.
    PubMed     Text format     Abstract available


  121. MASTANTUONO T, Starita N, Sapio D, D'Avanzo SA, et al
    The Effects of Vaccinium myrtillus Extract on Hamster Pial Microcirculation during Hypoperfusion-Reperfusion Injury.
    PLoS One. 2016;11:e0150659.
    PubMed     Text format     Abstract available


  122. CUNNINGHAM AL, Guentzel MN, Yu JJ, Hung CY, et al
    M-Cells Contribute to the Entry of an Oral Vaccine but Are Not Essential for the Subsequent Induction of Protective Immunity against Francisella tularensis.
    PLoS One. 2016;11:e0153402.
    PubMed     Text format     Abstract available


  123. COSTELLO R, Winthrop KL, Pye SR, Brown B, et al
    Influenza and Pneumococcal Vaccination Uptake in Patients with Rheumatoid Arthritis Treated with Immunosuppressive Therapy in the UK: A Retrospective Cohort Study Using Data from the Clinical Practice Research Datalink.
    PLoS One. 2016;11:e0153848.
    PubMed     Text format     Abstract available


  124. DHANDA SK, Vir P, Singla D, Gupta S, et al
    A Web-Based Platform for Designing Vaccines against Existing and Emerging Strains of Mycobacterium tuberculosis.
    PLoS One. 2016;11:e0153771.
    PubMed     Text format     Abstract available


  125. HIREMATH J, Kang KI, Xia M, Elaish M, et al
    Entrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs.
    PLoS One. 2016;11:e0151922.
    PubMed     Text format     Abstract available


  126. LINHARES DC, Johnson C, Morrison RB
    Correction: Economic Analysis of Vaccination Strategies for PRRS Control.
    PLoS One. 2016;11:e0150444.
    PubMed     Text format     Abstract available


  127. LHOMME E, Richert L, Moodie Z, Pasin C, et al
    Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy.
    PLoS One. 2016;11:e0152952.
    PubMed     Text format     Abstract available


  128. KJAERGAARD J, Stensballe LG, Birk NM, Nissen TN, et al
    Lack of a Negative Effect of BCG-Vaccination on Child Psychomotor Development: Results from the Danish Calmette Study - A Randomised Clinical Trial.
    PLoS One. 2016;11:e0154541.
    PubMed     Text format     Abstract available


  129. LAMB F, Ploner A, Fink K, Maeurer M, et al
    No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination.
    PLoS One. 2016;11:e0154296.
    PubMed     Text format     Abstract available


  130. HIRVE S, Newman LP, Paget J, Azziz-Baumgartner E, et al
    Influenza Seasonality in the Tropics and Subtropics - When to Vaccinate?
    PLoS One. 2016;11:e0153003.
    PubMed     Text format     Abstract available


  131. BIGAEVA E, Doorn Ev, Liu H, Hak E, et al
    Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability.
    PLoS One. 2016;11:e0154757.
    PubMed     Text format     Abstract available


  132. GWON YD, Kim S, Cho Y, Heo Y, et al
    Immunogenicity of Virus Like Particle Forming Baculoviral DNA Vaccine against Pandemic Influenza H1N1.
    PLoS One. 2016;11:e0154824.
    PubMed     Text format     Abstract available


  133. CAINI S, Andrade W, Badur S, Balmaseda A, et al
    Correction: Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination?
    PLoS One. 2016;11:e0155089.
    PubMed     Text format     Abstract available


  134. FONSECA JA, Cabrera-Mora M, Kashentseva EA, Villegas JP, et al
    A Plasmodium Promiscuous T Cell Epitope Delivered within the Ad5 Hexon Protein Enhances the Protective Efficacy of a Protein Based Malaria Vaccine.
    PLoS One. 2016;11:e0154819.
    PubMed     Text format     Abstract available


  135. WIJMENGA-MONSUUR AJ, van Westen E, Knol MJ, Jongerius RM, et al
    Correction: Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.
    PLoS One. 2016;11:e0155088.
    PubMed     Text format     Abstract available


  136. COSGROVE CA, Lacey CJ, Cope AV, Bartolf A, et al
    Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study.
    PLoS One. 2016;11:e0152038.
    PubMed     Text format     Abstract available


  137. ZHA J, Chi XW, Yu XL, Liu XM, et al
    Interleukin-1beta-Targeted Vaccine Improves Glucose Control and beta-Cell Function in a Diabetic KK-Ay Mouse Model.
    PLoS One. 2016;11:e0154298.
    PubMed     Text format     Abstract available


  138. MVULA H, Heinsbroek E, Chihana M, Crampin AC, et al
    Predictors of Uptake and Timeliness of Newly Introduced Pneumococcal and Rotavirus Vaccines, and of Measles Vaccine in Rural Malawi: A Population Cohort Study.
    PLoS One. 2016;11:e0154997.
    PubMed     Text format     Abstract available


  139. MARTIN SD, Brown SD, Wick DA, Nielsen JS, et al
    Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.
    PLoS One. 2016;11:e0155189.
    PubMed     Text format     Abstract available


  140. DEERE JD, Chang WL, Castillo LD, Schmidt KA, et al
    Utilizing a TLR5-Adjuvanted Cytomegalovirus as a Lentiviral Vaccine in the Nonhuman Primate Model for AIDS.
    PLoS One. 2016;11:e0155629.
    PubMed     Text format     Abstract available


  141. YU Z, Liu J, Wang X, Zhu X, et al
    Efficient Vaccine Distribution Based on a Hybrid Compartmental Model.
    PLoS One. 2016;11:e0155416.
    PubMed     Text format     Abstract available


  142. LU J, Wu P, Zhang X, Feng L, et al
    Immunopotentiators Improve the Efficacy of Oil-Emulsion-Inactivated Avian Influenza Vaccine in Chickens, Ducks and Geese.
    PLoS One. 2016;11:e0156573.
    PubMed     Text format     Abstract available


  143. ALLEN ER, van Diemen P, Yamaguchi Y, Lindemann C, et al
    MRI Based Localisation and Quantification of Abscesses following Experimental S. aureus Intravenous Challenge: Application to Vaccine Evaluation.
    PLoS One. 2016;11:e0154705.
    PubMed     Text format     Abstract available


  144. STONE J, Martin NK, Hickman M, Hellard M, et al
    The Potential Impact of a Hepatitis C Vaccine for People Who Inject Drugs: Is a Vaccine Needed in the Age of Direct-Acting Antivirals?
    PLoS One. 2016;11:e0156213.
    PubMed     Text format     Abstract available


  145. RAMANATHAN B, Poh CL, Kirk K, McBride WJ, et al
    Synthetic B-Cell Epitopes Eliciting Cross-Neutralizing Antibodies: Strategies for Future Dengue Vaccine.
    PLoS One. 2016;11:e0155900.
    PubMed     Text format     Abstract available


  146. KHAN SA, Desclozeaux M, Waugh C, Hanger J, et al
    Antibody and Cytokine Responses of Koalas (Phascolarctos cinereus) Vaccinated with Recombinant Chlamydial Major Outer Membrane Protein (MOMP) with Two Different Adjuvants.
    PLoS One. 2016;11:e0156094.
    PubMed     Text format     Abstract available


  147. LAUGHIN RC, Drake KL, Morrill JC, Adams LG, et al
    Correction: Correlative Gene Expression to Protective Seroconversion In Rift Valley Vaccinates.
    PLoS One. 2016;11:e0156469.
    PubMed     Text format     Abstract available


  148. NAVALPAKAM A, Dany M, Hajj Hussein I
    Behavioral Perceptions of Oakland University Female College Students towards Human Papillomavirus Vaccination.
    PLoS One. 2016;11:e0155955.
    PubMed     Text format     Abstract available


  149. VISSER O, Hautvast JL, van der Velden K, Hulscher ME, et al
    Intention to Accept Pertussis Vaccination for Cocooning: A Qualitative Study of the Determinants.
    PLoS One. 2016;11:e0155861.
    PubMed     Text format     Abstract available


  150. ADAMS J, McNaughton RJ, Wigham S, Flynn D, et al
    Acceptability of Parental Financial Incentives and Quasi-Mandatory Interventions for Preschool Vaccinations: Triangulation of Findings from Three Linked Studies.
    PLoS One. 2016;11:e0156843.
    PubMed     Text format     Abstract available


  151. KLUSHKINA VV, Kyuregyan KK, Kozhanova TV, Popova OE, et al
    Impact of Universal Hepatitis B Vaccination on Prevalence, Infection-Associated Morbidity and Mortality, and Circulation of Immune Escape Variants in Russia.
    PLoS One. 2016;11:e0157161.
    PubMed     Text format     Abstract available


  152. FULLEN DJ, Noulin N, Catchpole A, Fathi H, et al
    Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.
    PLoS One. 2016;11:e0157211.
    PubMed     Text format     Abstract available


  153. DOWALL SD, Graham VA, Rayner E, Hunter L, et al
    Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses.
    PLoS One. 2016;11:e0156637.
    PubMed     Text format     Abstract available


  154. LOMBARDI F, Belmonti S, Fabbiani M, Morandi M, et al
    Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine versus the 23-Valent Polysaccharide Vaccine in Unvaccinated HIV-Infected Adults: A Pilot, Prospective Controlled Study.
    PLoS One. 2016;11:e0156523.
    PubMed     Text format     Abstract available


  155. JANG H, Ngunjiri JM, Lee CW
    Association between Interferon Response and Protective Efficacy of NS1-Truncated Mutants as Influenza Vaccine Candidates in Chickens.
    PLoS One. 2016;11:e0156603.
    PubMed     Text format     Abstract available


  156. MICHEL G, Ferrua B, Munro P, Boyer L, et al
    Immunoadjuvant Properties of the Rho Activating Factor CNF1 in Prophylactic and Curative Vaccination against Leishmania infantum.
    PLoS One. 2016;11:e0156363.
    PubMed     Text format     Abstract available


  157. DUBE E, Gagnon D, Ouakki M, Bettinger JA, et al
    Understanding Vaccine Hesitancy in Canada: Results of a Consultation Study by the Canadian Immunization Research Network.
    PLoS One. 2016;11:e0156118.
    PubMed     Text format     Abstract available


  158. MCNEILLY C, Cosh S, Vu T, Nichols J, et al
    Predicted Coverage and Immuno-Safety of a Recombinant C-Repeat Region Based Streptococcus pyogenes Vaccine Candidate.
    PLoS One. 2016;11:e0156639.
    PubMed     Text format     Abstract available


  159. KILANY WH, Safwat M, Mohammed SM, Salim A, et al
    Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.
    PLoS One. 2016;11:e0156747.
    PubMed     Text format     Abstract available


  160. HEYDARCHI B, Center RJ, Gonelli C, Muller B, et al
    Repeated Vaccination of Cows with HIV Env gp140 during Subsequent Pregnancies Elicits and Sustains an Enduring Strong Env-Binding and Neutralising Antibody Response.
    PLoS One. 2016;11:e0157353.
    PubMed     Text format     Abstract available


  161. GULLBERG M, Lohse L, Botner A, McInerney GM, et al
    A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.
    PLoS One. 2016;11:e0157435.
    PubMed     Text format     Abstract available


  162. SPENSIERI F, Siena E, Borgogni E, Zedda L, et al
    Early Rise of Blood T Follicular Helper Cell Subsets and Baseline Immunity as Predictors of Persisting Late Functional Antibody Responses to Vaccination in Humans.
    PLoS One. 2016;11:e0157066.
    PubMed     Text format     Abstract available


  163. CHANG YC, Tung HJ, Hsu SW, Chen LS, et al
    Use of Seasonal Influenza Vaccination and Its Associated Factors among Elderly People with Disabilities in Taiwan: A Population-Based Study.
    PLoS One. 2016;11:e0158075.
    PubMed     Text format     Abstract available


  164. YOON S, Kim ED, Song MS, Han SJ, et al
    Eyedrop Vaccination Induced Systemic and Mucosal Immunity against Influenza Virus in Ferrets.
    PLoS One. 2016;11:e0157634.
    PubMed     Text format     Abstract available


  165. HARVEY MJ, Prosser LA, Messonnier ML, Hutton DW, et al
    Hitting the Optimal Vaccination Percentage and the Risks of Error: Why to Miss Right.
    PLoS One. 2016;11:e0156737.
    PubMed     Text format     Abstract available


  166. FENG XM, Zheng WY, Zhang HM, Shi WY, et al
    Vaccination with Bivalent DNA Vaccine of alpha1-Giardin and CWP2 Delivered by Attenuated Salmonella typhimurium Reduces Trophozoites and Cysts in the Feces of Mice Infected with Giardia lamblia.
    PLoS One. 2016;11:e0157872.
    PubMed     Text format     Abstract available


  167. GREENBERG RN, Hay CM, Stapleton JT, Marbury TC, et al
    A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN(R)) in 56-80-Year-Old Subjects.
    PLoS One. 2016;11:e0157335.
    PubMed     Text format     Abstract available


  168. AKIN L, Macabeo B, Caliskan Z, Altinel S, et al
    Cost-Effectiveness of Increasing Influenza Vaccination Coverage in Adults with Type 2 Diabetes in Turkey.
    PLoS One. 2016;11:e0157657.
    PubMed     Text format     Abstract available


  169. HART PJ, O'Shaughnessy CM, Siggins MK, Bobat S, et al
    Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.
    PLoS One. 2016;11:e0145945.
    PubMed     Text format     Abstract available


  170. RABINOWITZ M, Latella L, Stern C, Jost JT, et al
    Beliefs about Childhood Vaccination in the United States: Political Ideology, False Consensus, and the Illusion of Uniqueness.
    PLoS One. 2016;11:e0158382.
    PubMed     Text format     Abstract available


  171. THOMAS MA, Nyanhete T, Tuero I, Venzon D, et al
    Beyond Oncolytics: E1B55K-Deleted Adenovirus as a Vaccine Delivery Vector.
    PLoS One. 2016;11:e0158505.
    PubMed     Text format     Abstract available


  172. GILKEY MB, McRee AL, Magnus BE, Reiter PL, et al
    Vaccination Confidence and Parental Refusal/Delay of Early Childhood Vaccines.
    PLoS One. 2016;11:e0159087.
    PubMed     Text format     Abstract available


  173. MULLER L, Meyer M, Bauer RN, Zhou H, et al
    Effect of Broccoli Sprouts and Live Attenuated Influenza Virus on Peripheral Blood Natural Killer Cells: A Randomized, Double-Blind Study.
    PLoS One. 2016;11:e0147742.
    PubMed     Text format     Abstract available


  174. SCHIFFNER-ROHE J, Witt A, Hemmerling J, von Eiff C, et al
    Efficacy of PPV23 in Preventing Pneumococcal Pneumonia in Adults at Increased Risk--A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0146338.
    PubMed     Text format     Abstract available


  175. CARDENAS-GARCIA S, Dunwoody RP, Marcano V, Diel DG, et al
    Effects of Chicken Interferon Gamma on Newcastle Disease Virus Vaccine Immunogenicity.
    PLoS One. 2016;11:e0159153.
    PubMed     Text format     Abstract available


  176. HERMES R, Schwarzenberger F, Goritz F, Oh S, et al
    Ovarian down Regulation by GnRF Vaccination Decreases Reproductive Tract Tumour Size in Female White and Greater One-Horned Rhinoceroses.
    PLoS One. 2016;11:e0157963.
    PubMed     Text format     Abstract available


  177. BLANCO-HEREDIA J, Lecanda A, Valenzuela-Ponce H, Brander C, et al
    Identification of Immunogenic Cytotoxic T Lymphocyte Epitopes Containing Drug Resistance Mutations in Antiretroviral Treatment-Naive HIV-Infected Individuals.
    PLoS One. 2016;11:e0147571.
    PubMed     Text format     Abstract available


  178. CAO Y, Bansal GP, Merino K, Kumar N, et al
    Immunological Cross-Reactivity between Malaria Vaccine Target Antigen P48/45 in Plasmodium vivax and P. falciparum and Cross-Boosting of Immune Responses.
    PLoS One. 2016;11:e0158212.
    PubMed     Text format     Abstract available


  179. SPEAKE C, Pichugin A, Sahu T, Malkov V, et al
    Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein.
    PLoS One. 2016;11:e0159449.
    PubMed     Text format     Abstract available


  180. TRAVASSOS MA, Beyene B, Adam Z, Campbell JD, et al
    Immunization Coverage Surveys and Linked Biomarker Serosurveys in Three Regions in Ethiopia.
    PLoS One. 2016;11:e0149970.
    PubMed     Text format     Abstract available


  181. NGABO F, Mvundura M, Gazley L, Gatera M, et al
    The Economic Burden Attributable to a Child's Inpatient Admission for Diarrheal Disease in Rwanda.
    PLoS One. 2016;11:e0149805.
    PubMed     Text format     Abstract available


  182. BOLLAERTS K, Shinde V, Dos Santos G, Ferreira G, et al
    Application of Probabilistic Multiple-Bias Analyses to a Cohort- and a Case-Control Study on the Association between Pandemrix and Narcolepsy.
    PLoS One. 2016;11:e0149289.
    PubMed     Text format     Abstract available


  183. MANIGART O, Trotter C, Findlow H, Assefa A, et al
    A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt.
    PLoS One. 2016;11:e0147928.
    PubMed     Text format     Abstract available


  184. GOGOI-TIWARI J, Williams V, Waryah CB, Mathavan S, et al
    Intramammary Immunization of Pregnant Mice with Staphylococcal Protein A Reduces the Post-Challenge Mammary Gland Bacterial Load but Not Pathology.
    PLoS One. 2016;11:e0148383.
    PubMed     Text format     Abstract available


  185. CASARIN E, Lucchese L, Grazioli S, Facchin S, et al
    A New ELISA Using the ANANAS Technology Showing High Sensitivity to diagnose the Bovine Rhinotracheitis from Individual Sera to Pooled Milk.
    PLoS One. 2016;11:e0145912.
    PubMed     Text format     Abstract available


  186. PEDERSEN SR, Christensen JP, Buus S, Rasmussen M, et al
    Immunogenicity of HLA Class I and II Double Restricted Influenza A-Derived Peptides.
    PLoS One. 2016;11:e0145629.
    PubMed     Text format     Abstract available


  187. SUBHARAT S, Shu D, Zheng T, Buddle BM, et al
    Vaccination of Sheep with a Methanogen Protein Provides Insight into Levels of Antibody in Saliva Needed to Target Ruminal Methanogens.
    PLoS One. 2016;11:e0159861.
    PubMed     Text format     Abstract available


  188. LI M, Taylor EG, Atkins KE, Chapman GB, et al
    Stimulating Influenza Vaccination via Prosocial Motives.
    PLoS One. 2016;11:e0159780.
    PubMed     Text format     Abstract available


  189. SUZUKI Y, Odagiri T, Tashiro M, Nobusawa E, et al
    Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.
    PLoS One. 2016;11:e0160040.
    PubMed     Text format     Abstract available


  190. ZAMBONELLI C, Dey AK, Hilt S, Stephenson S, et al
    Generation and Characterization of a Bivalent HIV-1 Subtype C gp120 Protein Boost for Proof-of-Concept HIV Vaccine Efficacy Trials in Southern Africa.
    PLoS One. 2016;11:e0157391.
    PubMed     Text format     Abstract available


  191. REINTJES R, Das E, Klemm C, Richardus JH, et al
    "Pandemic Public Health Paradox": Time Series Analysis of the 2009/10 Influenza A / H1N1 Epidemiology, Media Attention, Risk Perception and Public Reactions in 5 European Countries.
    PLoS One. 2016;11:e0151258.
    PubMed     Text format     Abstract available


  192. TEN HAVE R, Reubsaet K, van Herpen P, Kersten G, et al
    Demonstrating Functional Equivalence of Pilot and Production Scale Freeze-Drying of BCG.
    PLoS One. 2016;11:e0151239.
    PubMed     Text format     Abstract available


  193. GONZALEZ-PENA D, Nixon SE, O'Connor JC, Southey BR, et al
    Microglia Transcriptome Changes in a Model of Depressive Behavior after Immune Challenge.
    PLoS One. 2016;11:e0150858.
    PubMed     Text format     Abstract available


  194. MUNANG'ANDU HM, Santi N, Fredriksen BN, Lokling KE, et al
    A Systematic Approach towards Optimizing a Cohabitation Challenge Model for Infectious Pancreatic Necrosis Virus in Atlantic Salmon (Salmo salar L.).
    PLoS One. 2016;11:e0148467.
    PubMed     Text format     Abstract available


  195. DANIELS-TREFFANDIER H, de Nie K, Marsay L, Dold C, et al
    Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles.
    PLoS One. 2016;11:e0148840.
    PubMed     Text format     Abstract available


  196. LOMBARD R, Doz E, Carreras F, Epardaud M, et al
    IL-17RA in Non-Hematopoietic Cells Controls CXCL-1 and 5 Critical to Recruit Neutrophils to the Lung of Mycobacteria-Infected Mice during the Adaptive Immune Response.
    PLoS One. 2016;11:e0149455.
    PubMed     Text format     Abstract available


  197. MARIMON JM, Ercibengoa M, Tamayo E, Alonso M, et al
    Long-Term Epidemiology of Streptococcus pneumoniae Serogroup 6 in a Region of Southern Europe with Special Reference to Serotype 6E.
    PLoS One. 2016;11:e0149047.
    PubMed     Text format     Abstract available


  198. ALVARADO-FACUNDO E, Vassell R, Schmeisser F, Weir JP, et al
    Glycosylation of Residue 141 of Subtype H7 Influenza A Hemagglutinin (HA) Affects HA-Pseudovirus Infectivity and Sensitivity to Site A Neutralizing Antibodies.
    PLoS One. 2016;11:e0149149.
    PubMed     Text format     Abstract available


  199. MUTURI-KIOI V, Lewis D, Launay O, Leroux-Roels G, et al
    Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review.
    PLoS One. 2016;11:e0157385.
    PubMed     Text format     Abstract available


  200. FELL DB, Wilson K, Ducharme R, Hawken S, et al
    Infant Respiratory Outcomes Associated with Prenatal Exposure to Maternal 2009 A/H1N1 Influenza Vaccination.
    PLoS One. 2016;11:e0160342.
    PubMed     Text format     Abstract available


  201. KUMAKECH E, Berggren V, Wabinga H, Lillsunde-Larsson G, et al
    Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix(R)) Pilot Project in Uganda.
    PLoS One. 2016;11:e0160099.
    PubMed     Text format     Abstract available


  202. ROTH A, Glaesener S, Schutz K, Meyer-Bahlburg A, et al
    Reduced Number of Transitional and Naive B Cells in Addition to Decreased BAFF Levels in Response to the T Cell Independent Immunogen Pneumovax(R)23.
    PLoS One. 2016;11:e0152215.
    PubMed     Text format     Abstract available


  203. GUPTA M, Angeli F, Bosma H, Rana M, et al
    Effectiveness of Multiple-Strategy Community Intervention in Reducing Geographical, Socioeconomic and Gender Based Inequalities in Maternal and Child Health Outcomes in Haryana, India.
    PLoS One. 2016;11:e0150537.
    PubMed     Text format     Abstract available


  204. VEGUILLA V, Lopez-Gatell H, Lopez-Martinez I, Aparicio-Antonio R, et al
    A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic.
    PLoS One. 2016;11:e0150428.
    PubMed     Text format     Abstract available


  205. KAWAHARA M, Hasegawa N, Takaku H
    Murine Splenic Natural Killer Cells Do Not Develop Immunological Memory after Re-Encounter with Mycobacterium bovis BCG.
    PLoS One. 2016;11:e0152051.
    PubMed     Text format     Abstract available


  206. MELO R, Richer L, Johnson DL, Gomes-Solecki M, et al
    Oral Immunization with OspC Does Not Prevent Tick-Borne Borrelia burgdorferi Infection.
    PLoS One. 2016;11:e0151850.
    PubMed     Text format     Abstract available


  207. MESHER D, Stanford E, White J, Findlow J, et al
    HPV Serology Testing Confirms High HPV Immunisation Coverage in England.
    PLoS One. 2016;11:e0150107.
    PubMed     Text format     Abstract available


  208. NORRIS A, Hachey K, Curtis A, Bourdeaux M, et al
    Crippling Violence: Conflict and Incident Polio in Afghanistan.
    PLoS One. 2016;11:e0149074.
    PubMed     Text format     Abstract available


  209. NGO CC, Massa HM, Thornton RB, Cripps AW, et al
    Predominant Bacteria Detected from the Middle Ear Fluid of Children Experiencing Otitis Media: A Systematic Review.
    PLoS One. 2016;11:e0150949.
    PubMed     Text format     Abstract available


  210. DEL AMO E, Esteva C, Hernandez-Bou S, Galles C, et al
    Serotypes and Clonal Diversity of Streptococcus pneumoniae Causing Invasive Disease in the Era of PCV13 in Catalonia, Spain.
    PLoS One. 2016;11:e0151125.
    PubMed     Text format     Abstract available


  211. POSUWAN N, Wanlapakorn N, Sa-Nguanmoo P, Wasitthankasem R, et al
    The Success of a Universal Hepatitis B Immunization Program as Part of Thailand's EPI after 22 Years' Implementation.
    PLoS One. 2016;11:e0150499.
    PubMed     Text format     Abstract available


  212. SZCZEPANEK SM, Roberts S, Rogers K, Cotte C, et al
    Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers.
    PLoS One. 2016;11:e0149261.
    PubMed     Text format     Abstract available


  213. XIONG W, Dong H, Wang J, Zou X, et al
    Analysis of Plasma Cytokine and Chemokine Profiles in Patients with and without Tuberculosis by Liquid Array-Based Multiplexed Immunoassays.
    PLoS One. 2016;11:e0148885.
    PubMed     Text format     Abstract available


  214. MCKINNEY BA, Lareau C, Oberg AL, Kennedy RB, et al
    The Integration of Epistasis Network and Functional Interactions in a GWAS Implicates RXR Pathway Genes in the Immune Response to Smallpox Vaccine.
    PLoS One. 2016;11:e0158016.
    PubMed     Text format     Abstract available


  215. PRAYGOD G, Mukerebe C, Magawa R, Jeremiah K, et al
    Indoor Air Pollution and Delayed Measles Vaccination Increase the Risk of Severe Pneumonia in Children: Results from a Case-Control Study in Mwanza, Tanzania.
    PLoS One. 2016;11:e0160804.
    PubMed     Text format     Abstract available


  216. HUMBERT MV, Hung MC, Phillips R, Akoto C, et al
    Vaccine Potential and Diversity of the Putative Cell Binding Factor (CBF, NMB0345/NEIS1825) Protein of Neisseria meningitidis.
    PLoS One. 2016;11:e0160403.
    PubMed     Text format     Abstract available


  217. MADAMPAGE CA, Wilson D, Townsend H, Crockford G, et al
    Cattle Immunized with a Recombinant Subunit Vaccine Formulation Exhibits a Trend towards Protection against Histophilus somni Bacterial Challenge.
    PLoS One. 2016;11:e0159070.
    PubMed     Text format     Abstract available


  218. GACH JS, Gorlani A, Dotsey EY, Becerra JC, et al
    HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects.
    PLoS One. 2016;11:e0160341.
    PubMed     Text format     Abstract available


  219. ANDERSON CS, DeDiego ML, Thakar J, Topham DJ, et al
    Novel Sequence-Based Mapping of Recently Emerging H5NX Influenza Viruses Reveals Pandemic Vaccine Candidates.
    PLoS One. 2016;11:e0160510.
    PubMed     Text format     Abstract available


  220. KESSANS SA, Linhart MD, Meador LR, Kilbourne J, et al
    Immunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles.
    PLoS One. 2016;11:e0151842.
    PubMed     Text format     Abstract available


  221. PORTER CK, Riddle MS, Alcala AN, Sack DA, et al
    An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coli.
    PLoS One. 2016;11:e0149358.
    PubMed     Text format     Abstract available


  222. DEY A, Molodecky NA, Verma H, Sharma P, et al
    Human Circulating Antibody-Producing B Cell as a Predictive Measure of Mucosal Immunity to Poliovirus.
    PLoS One. 2016;11:e0146010.
    PubMed     Text format     Abstract available


  223. HARALAMBIEVA IH, Zimmermann MT, Ovsyannikova IG, Grill DE, et al
    Whole Transcriptome Profiling Identifies CD93 and Other Plasma Cell Survival Factor Genes Associated with Measles-Specific Antibody Response after Vaccination.
    PLoS One. 2016;11:e0160970.
    PubMed     Text format     Abstract available


  224. VAN DER LINDEN M, Falkenhorst G, Perniciaro S, Fitzner C, et al
    Effectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in Germany.
    PLoS One. 2016;11:e0161257.
    PubMed     Text format     Abstract available


  225. BILLESKOV R, Tan EV, Cang M, Abalos RM, et al
    Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of Tuberculosis.
    PLoS One. 2016;11:e0161217.
    PubMed     Text format     Abstract available


  226. MAGINI D, Giovani C, Mangiavacchi S, Maccari S, et al
    Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge.
    PLoS One. 2016;11:e0161193.
    PubMed     Text format     Abstract available


  227. MALO CS, Renner DN, Huseby Kelcher AM, Jin F, et al
    The Effect of Vector Silencing during Picornavirus Vaccination against Experimental Melanoma and Glioma.
    PLoS One. 2016;11:e0162064.
    PubMed     Text format     Abstract available


  228. PATYKOWSKI J, Dell M, Gibson M
    Germination Ecology and Seed Dispersal of a Critically Endangered Plant: A Case Study of Pomaderris vacciniifolia (Round-Leaf Pomaderris).
    PLoS One. 2016;11:e0161665.
    PubMed     Text format     Abstract available


  229. RESENDE LA, Aguiar-Soares RD, Gama-Ker H, Roatt BM, et al
    Impact of LbSapSal Vaccine in Canine Immunological and Parasitological Features before and after Leishmania chagasi-Challenge.
    PLoS One. 2016;11:e0161169.
    PubMed     Text format     Abstract available


  230. LEE DH, Lee SH, Kim AR, Quan FS, et al
    Virus-Like Nanoparticle Vaccine Confers Protection against Toxoplasma gondii.
    PLoS One. 2016;11:e0161231.
    PubMed     Text format     Abstract available


  231. HOONAKKER ME, Verhagen LM, Pupo E, de Haan A, et al
    Vaccine-Mediated Activation of Human TLR4 Is Affected by Modulation of Culture Conditions during Whole-Cell Pertussis Vaccine Preparation.
    PLoS One. 2016;11:e0161428.
    PubMed     Text format     Abstract available


  232. LATASA C, Echeverz M, Garcia B, Gil C, et al
    Evaluation of a Salmonella Strain Lacking the Secondary Messenger C-di-GMP and RpoS as a Live Oral Vaccine.
    PLoS One. 2016;11:e0161216.
    PubMed     Text format     Abstract available


  233. CEBEY-LOPEZ M, Herberg J, Pardo-Seco J, Gomez-Carballa A, et al
    Does Viral Co-Infection Influence the Severity of Acute Respiratory Infection in Children?
    PLoS One. 2016;11:e0152481.
    PubMed     Text format     Abstract available


  234. KLAUSBERGER M, Tscheliessnig R, Neff S, Nachbagauer R, et al
    Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.
    PLoS One. 2016;11:e0153579.
    PubMed     Text format     Abstract available


  235. ZURAWSKI G, Zurawski S, Flamar AL, Richert L, et al
    Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques.
    PLoS One. 2016;11:e0153484.
    PubMed     Text format     Abstract available


  236. QUAN V, Verani JR, Cohen C, von Gottberg A, et al
    Invasive Group B Streptococcal Disease in South Africa: Importance of Surveillance Methodology.
    PLoS One. 2016;11:e0152524.
    PubMed     Text format     Abstract available


  237. GUO Z, Xiao D, Li D, Wang X, et al
    Predicting and Evaluating the Epidemic Trend of Ebola Virus Disease in the 2014-2015 Outbreak and the Effects of Intervention Measures.
    PLoS One. 2016;11:e0152438.
    PubMed     Text format     Abstract available


  238. HAMMAMI P, Lancelot R, Lesnoff M
    Modelling the Dynamics of Post-Vaccination Immunity Rate in a Population of Sahelian Sheep after a Vaccination Campaign against Peste des Petits Ruminants Virus.
    PLoS One. 2016;11:e0161769.
    PubMed     Text format     Abstract available


  239. CHURCHYARD G, Mlisana K, Karuna S, Williamson AL, et al
    Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants.
    PLoS One. 2016;11:e0161753.
    PubMed     Text format     Abstract available


  240. ALI Z, Harastani H, Hammadi M, Reslan L, et al
    Rotavirus Genotypes and Vaccine Effectiveness from a Sentinel, Hospital-Based, Surveillance Study for Three Consecutive Rotavirus Seasons in Lebanon.
    PLoS One. 2016;11:e0161345.
    PubMed     Text format     Abstract available


  241. KATIVHU CL, Libraty DH
    A Model to Explain How the Bacille Calmette Guerin (BCG) Vaccine Drives Interleukin-12 Production in Neonates.
    PLoS One. 2016;11:e0162148.
    PubMed     Text format     Abstract available


  242. TUNG IL, Machalek DA, Garland SM
    Attitudes, Knowledge and Factors Associated with Human Papillomavirus (HPV) Vaccine Uptake in Adolescent Girls and Young Women in Victoria, Australia.
    PLoS One. 2016;11:e0161846.
    PubMed     Text format     Abstract available


  243. WANG Z, Chen Y, Xie S, Lv H, et al
    Changing Epidemiological Characteristics of Hepatitis A in Zhejiang Province, China: Increased Susceptibility in Adults.
    PLoS One. 2016;11:e0153804.
    PubMed     Text format     Abstract available


  244. URANGA S, Marinova D, Martin C, Pardo J, et al
    Granzyme A Is Expressed in Mouse Lungs during Mycobacterium tuberculosis Infection but Does Not Contribute to Protection In Vivo.
    PLoS One. 2016;11:e0153028.
    PubMed     Text format     Abstract available


  245. CHANTHAVILAY P, Reinharz D, Mayxay M, Phongsavan K, et al
    Economic Evaluation of Screening Strategies Combined with HPV Vaccination of Preadolescent Girls for the Prevention of Cervical Cancer in Vientiane, Lao PDR.
    PLoS One. 2016;11:e0162915.
    PubMed     Text format     Abstract available


  246. OLIVEIRA ER, Goncalves AJ, Costa SM, Azevedo AS, et al
    Aspects of T Cell-Mediated Immunity Induced in Mice by a DNA Vaccine Based on the Dengue-NS1 Antigen after Challenge by the Intracerebral Route.
    PLoS One. 2016;11:e0163240.
    PubMed     Text format     Abstract available


  247. NOH JY, Park JK, Lee DH, Yuk SS, et al
    Chimeric Bivalent Virus-Like Particle Vaccine for H5N1 HPAI and ND Confers Protection against a Lethal Challenge in Chickens and Allows a Strategy of Differentiating Infected from Vaccinated Animals (DIVA).
    PLoS One. 2016;11:e0162946.
    PubMed     Text format     Abstract available


  248. AYALA AJ, Dimitrov KM, Becker CR, Goraichuk IV, et al
    Presence of Vaccine-Derived Newcastle Disease Viruses in Wild Birds.
    PLoS One. 2016;11:e0162484.
    PubMed     Text format     Abstract available


  249. JUON HS, Strong C, Kim F, Park E, et al
    Lay Health Worker Intervention Improved Compliance with Hepatitis B Vaccination in Asian Americans: Randomized Controlled Trial.
    PLoS One. 2016;11:e0162683.
    PubMed     Text format     Abstract available


  250. MOLBAK K, Hansen ND, Valentiner-Branth P
    Pre-Vaccination Care-Seeking in Females Reporting Severe Adverse Reactions to HPV Vaccine. A Registry Based Case-Control Study.
    PLoS One. 2016;11:e0162520.
    PubMed     Text format     Abstract available


  251. MAMEDOV T, Chichester JA, Jones RM, Ghosh A, et al
    Production of Functionally Active and Immunogenic Non-Glycosylated Protective Antigen from Bacillus anthracis in Nicotiana benthamiana by Co-Expression with Peptide-N-Glycosidase F (PNGase F) of Flavobacterium meningosepticum.
    PLoS One. 2016;11:e0153956.
    PubMed     Text format     Abstract available


  252. NI G, Chen S, Yang Y, Cummins SF, et al
    Investigation the Possibility of Using Peptides with a Helical Repeating Pattern of Hydro-Phobic and Hydrophilic Residues to Inhibit IL-10.
    PLoS One. 2016;11:e0153939.
    PubMed     Text format     Abstract available


  253. TANMOY AM, Ahmed AN, Arumugam R, Hossain B, et al
    Rotavirus Surveillance at a WHO-Coordinated Invasive Bacterial Disease Surveillance Site in Bangladesh: A Feasibility Study to Integrate Two Surveillance Systems.
    PLoS One. 2016;11:e0153582.
    PubMed     Text format     Abstract available


  254. NJOM NLEND AE, Nguwoh PS, Ngounouh CT, Tchidjou HK, et al
    HIV-Infected or -Exposed Children Exhibit Lower Immunogenicity to Hepatitis B Vaccine in Yaounde, Cameroon: An Appeal for Revised Policies in Tropical Settings?
    PLoS One. 2016;11:e0161714.
    PubMed     Text format     Abstract available


  255. WONG LP, Raja Muhammad Yusoff RN, Edib Z, Sam IC, et al
    Nationwide Survey of Knowledge and Health Beliefs regarding Human Papillomavirus among HPV-Vaccinated Female Students in Malaysia.
    PLoS One. 2016;11:e0163156.
    PubMed     Text format     Abstract available


  256. KORAM KA, Adu B, Ocran J, Karikari YS, et al
    Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-Immune Adults: A Phase 1, Double-Blinded Placebo Controlled Dosage Escalation Study.
    PLoS One. 2016;11:e0163066.
    PubMed     Text format     Abstract available


  257. SALK HM, Simon WL, Lambert ND, Kennedy RB, et al
    Taxa of the Nasal Microbiome Are Associated with Influenza-Specific IgA Response to Live Attenuated Influenza Vaccine.
    PLoS One. 2016;11:e0162803.
    PubMed     Text format     Abstract available


  258. POUWELS KB, Bozdemir SE, Yegenoglu S, Celebi S, et al
    Potential Cost-Effectiveness of RSV Vaccination of Infants and Pregnant Women in Turkey: An Illustration Based on Bursa Data.
    PLoS One. 2016;11:e0163567.
    PubMed     Text format     Abstract available


  259. SPRUIJT IT, de Lange MM, Dijkstra F, Donker GA, et al
    Long-Term Correlation between Influenza Vaccination Coverage and Incidence of Influenza-Like Illness in 14 European Countries.
    PLoS One. 2016;11:e0163508.
    PubMed     Text format     Abstract available


  260. DHARMASENA MN, Feuille CM, Starke CE, Bhagwat AA, et al
    Development of an Acid-Resistant Salmonella Typhi Ty21a Attenuated Vector For Improved Oral Vaccine Delivery.
    PLoS One. 2016;11:e0163511.
    PubMed     Text format     Abstract available


  261. THOMPSON M, Heath SL, Sweeton B, Williams K, et al
    DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus.
    PLoS One. 2016;11:e0163164.
    PubMed     Text format     Abstract available


  262. ROUXEL RN, Merour E, Biacchesi S, Bremont M, et al
    Complete Protection against Influenza Virus H1N1 Strain A/PR/8/34 Challenge in Mice Immunized with Non-Adjuvanted Novirhabdovirus Vaccines.
    PLoS One. 2016;11:e0164245.
    PubMed     Text format     Abstract available


  263. CHOI HG, Choi S, Back YW, Park HS, et al
    Mycobacterium tuberculosis Rv2882c Protein Induces Activation of Macrophages through TLR4 and Exhibits Vaccine Potential.
    PLoS One. 2016;11:e0164458.
    PubMed     Text format     Abstract available


  264. HADJIPANAYIS A, Efstathiou E, Alexandrou M, Panayiotou L, et al
    Nasopharyngeal Pneumococcal Carriage among Healthy Children in Cyprus Post Widespread Simultaneous Implementation of PCV10 and PCV13 Vaccines.
    PLoS One. 2016;11:e0163269.
    PubMed     Text format     Abstract available


  265. SEDEGAH M, Peters B, Hollingdale MR, Ganeshan HD, et al
    Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes.
    PLoS One. 2016;11:e0163026.
    PubMed     Text format     Abstract available


  266. FABER BW, Hellwig S, Houard S, Havelange N, et al
    Production, Quality Control, Stability and Pharmacotoxicity of a Malaria Vaccine Comprising Three Highly Similar PfAMA1 Protein Molecules to Overcome Antigenic Variation.
    PLoS One. 2016;11:e0164053.
    PubMed     Text format     Abstract available


  267. HARRISON D, Wilding J, Bowman A, Fuller A, et al
    Using YouTube to Disseminate Effective Vaccination Pain Treatment for Babies.
    PLoS One. 2016;11:e0164123.
    PubMed     Text format     Abstract available


  268. SPEAKE C, Pichugin A, Sahu T, Malkov V, et al
    Correction: Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein.
    PLoS One. 2016;11:e0165489.
    PubMed     Text format     Abstract available


  269. FLYNN JA, Durr E, Swoyer R, Cejas PJ, et al
    Stability Characterization of a Vaccine Antigen Based on the Respiratory Syncytial Virus Fusion Glycoprotein.
    PLoS One. 2016;11:e0164789.
    PubMed     Text format     Abstract available


  270. XIE J, Codd C, Mo K, He Y, et al
    Differential Adverse Event Profiles Associated with BCG as a Preventive Tuberculosis Vaccine or Therapeutic Bladder Cancer Vaccine Identified by Comparative Ontology-Based VAERS and Literature Meta-Analysis.
    PLoS One. 2016;11:e0164792.
    PubMed     Text format     Abstract available


  271. TALAAT KR, Ellis RD, Hurd J, Hentrich A, et al
    Safety and Immunogenicity of Pfs25-EPA/Alhydrogel(R), a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naive Adults.
    PLoS One. 2016;11:e0163144.
    PubMed     Text format     Abstract available


  272. COLLINSON-PAUTZ MR, Slawin KM, Levitt JM, Spencer DM, et al
    MyD88/CD40 Genetic Adjuvant Function in Cutaneous Atypical Antigen-Presenting Cells Contributes to DNA Vaccine Immunogenicity.
    PLoS One. 2016;11:e0164547.
    PubMed     Text format     Abstract available


  273. PATEL MC, Wang W, Pletneva LM, Rajagopala SV, et al
    Enterovirus D-68 Infection, Prophylaxis, and Vaccination in a Novel Permissive Animal Model, the Cotton Rat (Sigmodon hispidus).
    PLoS One. 2016;11:e0166336.
    PubMed     Text format     Abstract available


  274. LAZARUS R, Kelly S, Snape MD, Vandermeulen C, et al
    Antibody Persistence and Booster Responses to Split-Virion H5N1 Avian Influenza Vaccine in Young and Elderly Adults.
    PLoS One. 2016;11:e0165384.
    PubMed     Text format     Abstract available


  275. LEE D, Park SM
    Cost-Effectiveness Analysis of Hepatitis B Vaccination Strategies to Prevent Perinatal Transmission in North Korea: Selective Vaccination vs. Universal Vaccination.
    PLoS One. 2016;11:e0165879.
    PubMed     Text format     Abstract available


  276. GUPTA S, Chaudhary K, Dhanda SK, Kumar R, et al
    A Platform for Designing Genome-Based Personalized Immunotherapy or Vaccine against Cancer.
    PLoS One. 2016;11:e0166372.
    PubMed     Text format     Abstract available


  277. FABIANI M, Riccardo F, Di Napoli A, Gargiulo L, et al
    Differences in Influenza Vaccination Coverage between Adult Immigrants and Italian Citizens at Risk for Influenza-Related Complications: A Cross-Sectional Study.
    PLoS One. 2016;11:e0166517.
    PubMed     Text format     Abstract available


  278. KAMBIRE D, Soeters HM, Ouedraogo-Traore R, Medah I, et al
    Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine-Burkina Faso, 2011-2013.
    PLoS One. 2016;11:e0166384.
    PubMed     Text format     Abstract available


  279. MINCHOLE E, Figueredo AL, Omenaca M, Panadero C, et al
    Seasonal Influenza A H1N1pdm09 Virus and Severe Outcomes: A Reason for Broader Vaccination in Non-Elderly, At-Risk People.
    PLoS One. 2016;11:e0165711.
    PubMed     Text format     Abstract available


  280. LINDSTRAND A, Kalyango J, Alfven T, Darenberg J, et al
    Pneumococcal Carriage in Children under Five Years in Uganda-Will Present Pneumococcal Conjugate Vaccines Be Appropriate?
    PLoS One. 2016;11:e0166018.
    PubMed     Text format     Abstract available


  281. WANG Y, Vlasova A, Velasquez DE, Saif LJ, et al
    Skin Vaccination against Rotavirus Using Microneedles: Proof of Concept in Gnotobiotic Piglets.
    PLoS One. 2016;11:e0166038.
    PubMed     Text format     Abstract available


  282. COTE-GRAVEL J, Brouillette E, Obradovic N, Ster C, et al
    Characterization of a vraG Mutant in a Genetically Stable Staphylococcus aureus Small-Colony Variant and Preliminary Assessment for Use as a Live-Attenuated Vaccine against Intrammamary Infections.
    PLoS One. 2016;11:e0166621.
    PubMed     Text format     Abstract available


  283. AHONKHAI V, Martins SF, Portet A, Lumpkin M, et al
    Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.
    PLoS One. 2016;11:e0166515.
    PubMed     Text format     Abstract available


  284. FLOOD A, Estrada M, McAdams D, Ji Y, et al
    Development of a Freeze-Dried, Heat-Stable Influenza Subunit Vaccine Formulation.
    PLoS One. 2016;11:e0164692.
    PubMed     Text format     Abstract available


  285. BALDO V, Cocchio S, Gallo T, Furlan P, et al
    Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.
    PLoS One. 2016;11:e0166637.
    PubMed     Text format     Abstract available


  286. CARVALHO TF, Haddad JP, Paixao TA, Santos RL, et al
    Meta-Analysis and Advancement of Brucellosis Vaccinology.
    PLoS One. 2016;11:e0166582.
    PubMed     Text format     Abstract available


  287. CRANK MC, Wilson EM, Novik L, Enama ME, et al
    Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012).
    PLoS One. 2016;11:e0166393.
    PubMed     Text format     Abstract available


  288. ROMLEY J, Goutam P, Sood N
    National Survey Indicates that Individual Vaccination Decisions Respond Positively to Community Vaccination Rates.
    PLoS One. 2016;11:e0166858.
    PubMed     Text format     Abstract available


  289. NUNES AM, Ribeiro GS, Ferreira IE, Moura AR, et al
    Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil.
    PLoS One. 2016;11:e0166475.
    PubMed     Text format     Abstract available


  290. RASHID S, Labani S, Das BC
    Knowledge, Awareness and Attitude on HPV, HPV Vaccine and Cervical Cancer among the College Students in India.
    PLoS One. 2016;11:e0166713.
    PubMed     Text format     Abstract available


  291. HILLS T, Jakeman PG, Carlisle RC, Klenerman P, et al
    A Rapid-Response Humoral Vaccine Platform Exploiting Pre-Existing Non-Cognate Populations of Anti-Vaccine or Anti-Viral CD4+ T Helper Cells to Confirm B Cell Activation.
    PLoS One. 2016;11:e0166383.
    PubMed     Text format     Abstract available


  292. VOINSON M, Billiard S, Alvergne A
    Correction: Beyond Rational Decision-Making: Modelling the Influence of Cognitive Biases on the Dynamics of Vaccination Coverage.
    PLoS One. 2016;11:e0167842.
    PubMed     Text format     Abstract available


  293. TRYFINOPOULOU K, Kesanopoulos K, Xirogianni A, Marmaras N, et al
    Meningococcal Carriage in Military Recruits and University Students during the Pre MenB Vaccination Era in Greece (2014-2015).
    PLoS One. 2016;11:e0167404.
    PubMed     Text format     Abstract available


  294. NUGENT G, Yockney IJ, Whitford EJ, Cross ML, et al
    Field Trial of an Aerially-Distributed Tuberculosis Vaccine in a Low-Density Wildlife Population of Brushtail Possums (Trichosurus vulpecula).
    PLoS One. 2016;11:e0167144.
    PubMed     Text format     Abstract available


  295. BENARD A, Sala C, Pluschke G
    Mycobacterium ulcerans Mouse Model Refinement for Pre-Clinical Profiling of Vaccine Candidates.
    PLoS One. 2016;11:e0167059.
    PubMed     Text format     Abstract available


  296. NJOKU OS, Manak MM, O'Connell RJ, Shutt AL, et al
    An Evaluation of Selected Populations for HIV-1 Vaccine Cohort Development in Nigeria.
    PLoS One. 2016;11:e0166711.
    PubMed     Text format     Abstract available


  297. ZHENG X, Zhang N, Zhang X, Hao L, et al
    Correction: Investigation of a Measles Outbreak in China to Identify Gaps in Vaccination Coverage, Routes of Transmission, and Interventions.
    PLoS One. 2016;11:e0168222.
    PubMed     Text format     Abstract available


  298. GUNNALA R, Ogbuanu IU, Adegoke OJ, Scobie HM, et al
    Routine Vaccination Coverage in Northern Nigeria: Results from 40 District-Level Cluster Surveys, 2014-2015.
    PLoS One. 2016;11:e0167835.
    PubMed     Text format     Abstract available


  299. SAMMER D, Krause K, Gube M, Wagner K, et al
    Hydrophobins in the Life Cycle of the Ectomycorrhizal Basidiomycete Tricholoma vaccinum.
    PLoS One. 2016;11:e0167773.
    PubMed     Text format     Abstract available


  300. MENSAH VA, Gueye A, Ndiaye M, Edwards NJ, et al
    Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.
    PLoS One. 2016;11:e0167951.
    PubMed     Text format     Abstract available


  301. VIARD JP, Assuied A, Levy Y, Souberbielle JC, et al
    No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected Adults.
    PLoS One. 2016;11:e0168640.
    PubMed     Text format     Abstract available


  302. WANG B, Russell ML, Moss L, Fonseca K, et al
    Effect of Influenza Vaccination of Children on Infection Rate in Hutterite Communities: Follow-Up Study of a Randomized Trial.
    PLoS One. 2016;11:e0167281.
    PubMed     Text format     Abstract available


  303. DALZON B, Lebas C, Jimenez G, Gutjahr A, et al
    Poly(Lactic Acid) Nanoparticles Targeting alpha5beta1 Integrin as Vaccine Delivery Vehicle, a Prospective Study.
    PLoS One. 2016;11:e0167663.
    PubMed     Text format     Abstract available


  304. YASUDA T, Ura T, Taniguchi M, Yoshida H, et al
    Intradermal Delivery of Antigens Enhances Specific IgG and Diminishes IgE Production: Potential Use for Vaccination and Allergy Immunotherapy.
    PLoS One. 2016;11:e0167952.
    PubMed     Text format     Abstract available


  305. DE OLIVEIRA LH, Camacho LA, Coutinho ES, Martinez-Silveira MS, et al
    Impact and Effectiveness of 10 and 13-Valent Pneumococcal Conjugate Vaccines on Hospitalization and Mortality in Children Aged Less than 5 Years in Latin American Countries: A Systematic Review.
    PLoS One. 2016;11:e0166736.
    PubMed     Text format     Abstract available


  306. WONG C, Jiang M, You JH
    Potential Cost-Effectiveness of an Influenza Vaccination Program Offering Microneedle Patch for Vaccine Delivery in Children.
    PLoS One. 2016;11:e0169030.
    PubMed     Text format     Abstract available


  307. LAMBKIN-WILLIAMS R, Gelder C, Broughton R, Mallett CP, et al
    An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Inf
    PLoS One. 2016;11:e0163089.
    PubMed     Text format     Abstract available


  308. TOTA JE, Jiang M, Ramanakumar AV, Walter SD, et al
    Epidemiologic Evaluation of Human Papillomavirus Type Competition and the Potential for Type Replacement Post-Vaccination.
    PLoS One. 2016;11:e0166329.
    PubMed     Text format     Abstract available



  309. Correction: A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.
    PLoS One. 2016;11:e0169025.
    PubMed     Text format     Abstract available


  310. MBUNDA T, Tarimo EA, Chalamilla G, Bakari M, et al
    The Influence of Community Members on Participation by Youth in an HIV Vaccine Trial in Tanzania.
    PLoS One. 2016;11:e0168660.
    PubMed     Text format     Abstract available


  311. SEDEGAH M, Peters B, Hollingdale MR, Ganeshan HD, et al
    Correction: Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes.
    PLoS One. 2016;11:e0168952.
    PubMed     Text format     Abstract available


  312. LAHEY T, Laddy D, Hill K, Schaeffer J, et al
    Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis.
    PLoS One. 2016;11:e0168521.
    PubMed     Text format     Abstract available


  313. ROSSI R, Assaad R, Rebeschini A, Hamadeh R, et al
    Vaccination Coverage Cluster Surveys in Middle Dreib - Akkar, Lebanon: Comparison of Vaccination Coverage in Children Aged 12-59 Months Pre- and Post-Vaccination Campaign.
    PLoS One. 2016;11:e0168145.
    PubMed     Text format     Abstract available


  314. DANGOR Z, Cutland CL, Izu A, Kwatra G, et al
    Temporal Changes in Invasive Group B Streptococcus Serotypes: Implications for Vaccine Development.
    PLoS One. 2016;11:e0169101.
    PubMed     Text format     Abstract available


    January 2015
  315. SONG YJ, Lim J, Park WS, Sohn H, et al
    Seropositivity among Korean Young Adults Approximately 2 Years after a Single-Dose Vaccination against Hepatitis A Virus.
    PLoS One. 2015;10:e0142297.
    PubMed     Text format     Abstract available


  316. HUANG D, Peng WJ, Ye Q, Liu XP, et al
    Serum-Free Suspension Culture of MDCK Cells for Production of Influenza H1N1 Vaccines.
    PLoS One. 2015;10:e0141686.
    PubMed     Text format     Abstract available


  317. SHEEHAN S, Harris SA, Satti I, Hokey DA, et al
    A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults.
    PLoS One. 2015;10:e0141687.
    PubMed     Text format     Abstract available



  318. Correction: Deep Sequencing for Evaluation of Genetic Stability of Influenza A/California/07/2009 (H1N1) Vaccine Viruses.
    PLoS One. 2015;10:e0142248.
    PubMed     Text format     Abstract available


  319. RAHIMI P, Vahabpour R, Aghasadeghi MR, Sadat SM, et al
    Correction: Neutralizing Antibody Response after Intramuscular Purified Vero Cell Rabies Vaccination (PVRV) in Iranian Patients with Specific Medical Conditions.
    PLoS One. 2015;10:e0142244.
    PubMed     Text format     Abstract available


  320. RAMANAIK S, McClarty LM, Khan S, Ramesh BM, et al
    Frontline Health Service Providers' Perspectives on HIV Vaccine Trials among Female Sex Workers and Men Who Have Sex with Men in Karnataka, South India.
    PLoS One. 2015;10:e0141822.
    PubMed     Text format     Abstract available


  321. CALDEIRA J, Bustos J, Peabody J, Chackerian B, et al
    Epitope-Specific Anti-hCG Vaccines on a Virus Like Particle Platform.
    PLoS One. 2015;10:e0141407.
    PubMed     Text format     Abstract available


  322. JINDRA C, Huber B, Shafti-Keramat S, Wolschek M, et al
    Correction: Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach.
    PLoS One. 2015;10:e0143269.
    PubMed     Text format     Abstract available


  323. GUPTA J, Pathak M, Misra S, Misra-Bhattacharya S, et al
    Immunogenicity and Protective Efficacy of Brugia malayi Heavy Chain Myosin as Homologous DNA, Protein and Heterologous DNA/Protein Prime Boost Vaccine in Rodent Model.
    PLoS One. 2015;10:e0142548.
    PubMed     Text format     Abstract available


  324. KHAN MU, Ahmad A, Aqeel T, Akbar N, et al
    A Cross-Sectional Survey of Healthcare Workers on the Knowledge and Attitudes towards Polio Vaccination in Pakistan.
    PLoS One. 2015;10:e0142485.
    PubMed     Text format     Abstract available


  325. GHAFFARI-NAZARI H, Tavakkol-Afshari J, Jaafari MR, Tahaghoghi-Hajghorbani S, et al
    Improving Multi-Epitope Long Peptide Vaccine Potency by Using a Strategy that Enhances CD4+ T Help in BALB/c Mice.
    PLoS One. 2015;10:e0142563.
    PubMed     Text format     Abstract available


  326. DOELLINGER J, Schaade L, Nitsche A
    Comparison of the Cowpox Virus and Vaccinia Virus Mature Virion Proteome: Analysis of the Species- and Strain-Specific Proteome.
    PLoS One. 2015;10:e0141527.
    PubMed     Text format     Abstract available


  327. ZHU F, Chen T, Zhang Y, Sun H, et al
    A Novel Adeno-Associated Virus-Based Genetic Vaccine Encoding the Hepatitis C Virus NS3/4 Protein Exhibits Immunogenic Properties in Mice Superior to Those of an NS3-Protein-Based Vaccine.
    PLoS One. 2015;10:e0142349.
    PubMed     Text format     Abstract available


  328. JANSEN K, Thamm M, Bock CT, Scheufele R, et al
    High Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in Germany.
    PLoS One. 2015;10:e0142515.
    PubMed     Text format     Abstract available


  329. GREENBERG RN, Hurley MY, Dinh DV, Mraz S, et al
    Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis.
    PLoS One. 2015;10:e0142802.
    PubMed     Text format     Abstract available


  330. BUNYASI EW, Tameris M, Geldenhuys H, Schmidt BM, et al
    Evaluation of Xpert(R) MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine Trial.
    PLoS One. 2015;10:e0141623.
    PubMed     Text format     Abstract available


  331. KING DF, McKay PF, Mann JF, Jones CB, et al
    Plasmid DNA Vaccine Co-Immunisation Modulates Cellular and Humoral Immune Responses Induced by Intranasal Inoculation in Mice.
    PLoS One. 2015;10:e0141557.
    PubMed     Text format     Abstract available


  332. GOMEZ CE, Perdiguero B, Garcia-Arriaza J, Cepeda V, et al
    A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART.
    PLoS One. 2015;10:e0141456.
    PubMed     Text format     Abstract available


  333. DEAN GS, Clifford D, Whelan AO, Tchilian EZ, et al
    Protection Induced by Simultaneous Subcutaneous and Endobronchial Vaccination with BCG/BCG and BCG/Adenovirus Expressing Antigen 85A against Mycobacterium bovis in Cattle.
    PLoS One. 2015;10:e0142270.
    PubMed     Text format     Abstract available


  334. PINZAN CF, Sardinha-Silva A, Almeida F, Lai L, et al
    Vaccination with Recombinant Microneme Proteins Confers Protection against Experimental Toxoplasmosis in Mice.
    PLoS One. 2015;10:e0143087.
    PubMed     Text format     Abstract available


  335. ADHIKARI RP, Kort T, Shulenin S, Kanipakala T, et al
    Correction: Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.
    PLoS One. 2015;10:e0143493.
    PubMed     Text format     Abstract available


  336. KHAN F, Porter M, Schwenk R, DeBot M, et al
    Head-to-Head Comparison of Soluble vs. Qbeta VLP Circumsporozoite Protein Vaccines Reveals Selective Enhancement of NANP Repeat Responses.
    PLoS One. 2015;10:e0142035.
    PubMed     Text format     Abstract available


  337. GARCIA-KNIGHT MA, Nduati E, Hassan AS, Gambo F, et al
    Altered Memory T-Cell Responses to Bacillus Calmette-Guerin and Tetanus Toxoid Vaccination and Altered Cytokine Responses to Polyclonal Stimulation in HIV-Exposed Uninfected Kenyan Infants.
    PLoS One. 2015;10:e0143043.
    PubMed     Text format     Abstract available


  338. MAHMUD SM, Bozat-Emre S, Hammond G, Elliott L, et al
    Did the H1N1 Vaccine Reduce the Risk of Admission with Influenza and Pneumonia during the Pandemic?
    PLoS One. 2015;10:e0142754.
    PubMed     Text format     Abstract available


  339. VOINSON M, Billiard S, Alvergne A
    Beyond Rational Decision-Making: Modelling the Influence of Cognitive Biases on the Dynamics of Vaccination Coverage.
    PLoS One. 2015;10:e0142990.
    PubMed     Text format     Abstract available


  340. STENFELDT C, Eschbaumer M, Pacheco JM, Rekant SI, et al
    Pathogenesis of Primary Foot-and-Mouth Disease Virus Infection in the Nasopharynx of Vaccinated and Non-Vaccinated Cattle.
    PLoS One. 2015;10:e0143666.
    PubMed     Text format     Abstract available


  341. THRANE S, Janitzek CM, Agerbaek MO, Ditlev SB, et al
    A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA.
    PLoS One. 2015;10:e0143071.
    PubMed     Text format     Abstract available


  342. LEUNG-THEUNG-LONG S, Gouanvic M, Coupet CA, Ray A, et al
    A Novel MVA-Based Multiphasic Vaccine for Prevention or Treatment of Tuberculosis Induces Broad and Multifunctional Cell-Mediated Immunity in Mice and Primates.
    PLoS One. 2015;10:e0143552.
    PubMed     Text format     Abstract available


  343. OLIVEIRA TL, Grassmann AA, Schuch RA, Seixas Neto AC, et al
    Evaluation of the Leptospira interrogans Outer Membrane Protein OmpL37 as a Vaccine Candidate.
    PLoS One. 2015;10:e0142821.
    PubMed     Text format     Abstract available


  344. LUCI C, Bekri S, Bihl F, Pini J, et al
    NKp46+ Innate Lymphoid Cells Dampen Vaginal CD8 T Cell Responses following Local Immunization with a Cholera Toxin-Based Vaccine.
    PLoS One. 2015;10:e0143224.
    PubMed     Text format     Abstract available


  345. MARTIN V, Pascual E, Avia M, Pena L, et al
    Protective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell Responses.
    PLoS One. 2015;10:e0143273.
    PubMed     Text format     Abstract available


  346. XIE E, Kotha A, Biaco T, Sedani N, et al
    Oral Delivery of a Novel Recombinant Streptococcus mitis Vector Elicits Robust Vaccine Antigen-Specific Oral Mucosal and Systemic Antibody Responses and T Cell Tolerance.
    PLoS One. 2015;10:e0143422.
    PubMed     Text format     Abstract available


  347. JOHANSSON KA, Memirie ST, Pecenka C, Jamison DT, et al
    Health Gains and Financial Protection from Pneumococcal Vaccination and Pneumonia Treatment in Ethiopia: Results from an Extended Cost-Effectiveness Analysis.
    PLoS One. 2015;10:e0142691.
    PubMed     Text format     Abstract available


  348. SHI J, Zhang J, Li S, Sun J, et al
    Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.
    PLoS One. 2015;10:e0144475.
    PubMed     Text format     Abstract available


  349. SLUNGE D
    The Willingness to Pay for Vaccination against Tick-Borne Encephalitis and Implications for Public Health Policy: Evidence from Sweden.
    PLoS One. 2015;10:e0143875.
    PubMed     Text format     Abstract available


  350. SPIES C, Luetz A, Lachmann G, Renius M, et al
    Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial.
    PLoS One. 2015;10:e0144003.
    PubMed     Text format     Abstract available


  351. LINHARES DC, Johnson C, Morrison RB
    Economic Analysis of Vaccination Strategies for PRRS Control.
    PLoS One. 2015;10:e0144265.
    PubMed     Text format     Abstract available


  352. ALI A, Kazi AM, Cortese MM, Fleming JA, et al
    Correction: Impact of Withholding Breastfeeding at the Time of Vaccination on the Immunogenicity of Oral Rotavirus Vaccine-A Randomized Trial.
    PLoS One. 2015;10:e0145568.
    PubMed     Text format     Abstract available


  353. ALVES J, Madureira P, Baltazar MT, Barros L, et al
    A Safe and Stable Neonatal Vaccine Targeting GAPDH Confers Protection against Group B Streptococcus Infections in Adult Susceptible Mice.
    PLoS One. 2015;10:e0144196.
    PubMed     Text format     Abstract available


  354. HALFORD WP, Geltz J, Messer RJ, Hasenkrug KJ, et al
    Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2.
    PLoS One. 2015;10:e0145228.
    PubMed     Text format     Abstract available


  355. WIJMENGA-MONSUUR AJ, van Westen E, Knol MJ, Jongerius RM, et al
    Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.
    PLoS One. 2015;10:e0144739.
    PubMed     Text format     Abstract available


  356. INIC-KANADA A, Stojanovic M, Schlacher S, Stein E, et al
    Delivery of a Chlamydial Adhesin N-PmpC Subunit Vaccine to the Ocular Mucosa Using Particulate Carriers.
    PLoS One. 2015;10:e0144380.
    PubMed     Text format     Abstract available


  357. WARFIELD KL, Dye JM, Wells JB, Unfer RC, et al
    Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles.
    PLoS One. 2015;10:e0118881.
    PubMed     Text format     Abstract available


  358. LUCAS A, Lucas M, Strhyn A, Keane NM, et al
    Abacavir-Reactive Memory T Cells Are Present in Drug Naive Individuals.
    PLoS One. 2015;10:e0117160.
    PubMed     Text format     Abstract available


  359. CHENG X, Guan W, Sun S, Li B, et al
    Stable Human Hepatoma Cell Lines for Efficient Regulated Expression of Nucleoside/Nucleotide Analog Resistant and Vaccine Escape Hepatitis B Virus Variants and Woolly Monkey Hepatitis B Virus.
    PLoS One. 2015;10:e0145746.
    PubMed     Text format     Abstract available


  360. COX F, Baart M, Huizingh J, Tolboom J, et al
    Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells.
    PLoS One. 2015;10:e0145243.
    PubMed     Text format     Abstract available


  361. DE ANDRADE PEREIRA B, E Maduro Bouillet L, Dorigo NA, Fraefel C, et al
    Adenovirus Specific Pre-Immunity Induced by Natural Route of Infection Does Not Impair Transduction by Adenoviral Vaccine Vectors in Mice.
    PLoS One. 2015;10:e0145260.
    PubMed     Text format     Abstract available


  362. DASSAH S, Sakyi SA, Frempong MT, Luuse AT, et al
    Seroconversion of Hepatitis B Vaccine in Young Children in the Kassena Nankana District of Ghana: A Cross-Sectional Study.
    PLoS One. 2015;10:e0145209.
    PubMed     Text format     Abstract available


  363. LIAO TA, Lau A, Joseph S, Hytonen V, et al
    Improving the Immunogenicity of the Mycobacterium bovis BCG Vaccine by Non-Genetic Bacterial Surface Decoration Using the Avidin-Biotin System.
    PLoS One. 2015;10:e0145833.
    PubMed     Text format     Abstract available


  364. CHEN HW, Hu HM, Wu SH, Chiang CY, et al
    The Immunodominance Change and Protection of CD4+ T-Cell Responses Elicited by an Envelope Protein Domain III-Based Tetravalent Dengue Vaccine in Mice.
    PLoS One. 2015;10:e0145717.
    PubMed     Text format     Abstract available


  365. VAN DEN BERG S, Koedijk DG, Back JW, Neef J, et al
    Active Immunization with an Octa-Valent Staphylococcus aureus Antigen Mixture in Models of S. aureus Bacteremia and Skin Infection in Mice.
    PLoS One. 2015;10:e0116847.
    PubMed     Text format     Abstract available


  366. KAYINA V, Kyobe S, Katabazi FA, Kigozi E, et al
    Pertussis prevalence and its determinants among children with persistent cough in urban Uganda.
    PLoS One. 2015;10:e0123240.
    PubMed     Text format     Abstract available


  367. SU Q, Yi Y, Qiu F, Lu X, et al
    Immune responses to HBsAg conjugated to protein D of non-typeable Haemophilus influenzae in mice.
    PLoS One. 2015;10:e0117736.
    PubMed     Text format     Abstract available


  368. SAXENA S, Khan N, Dehinwal R, Kumar A, et al
    Conserved surface accessible nucleoside ABC transporter component SP0845 is essential for pneumococcal virulence and confers protection in vivo.
    PLoS One. 2015;10:e0118154.
    PubMed     Text format     Abstract available


  369. GRIMM SK, Battles MB, Ackerman ME
    Directed Evolution of a Yeast-Displayed HIV-1 SOSIP gp140 Spike Protein toward Improved Expression and Affinity for Conformational Antibodies.
    PLoS One. 2015;10:e0117227.
    PubMed     Text format     Abstract available


  370. GONG W, Wang P, Xiong X, Jiao J, et al
    Chloroform-Methanol Residue of Coxiella burnetii Markedly Potentiated the Specific Immunoprotection Elicited by a Recombinant Protein Fragment rOmpB-4 Derived from Outer Membrane Protein B of Rickettsia rickettsii in C3H/HeN Mice.
    PLoS One. 2015;10:e0124664.
    PubMed     Text format     Abstract available


  371. MARTINEZ O, Miranda E, Ramirez M, Santos S, et al
    Immunomodulator-based enhancement of anti smallpox immune responses.
    PLoS One. 2015;10:e0123113.
    PubMed     Text format     Abstract available


  372. CHUANG YC, Huang YL, Tseng KC, Yen CH, et al
    Social Capital and Health-Protective Behavior Intentions in an Influenza Pandemic.
    PLoS One. 2015;10:e0122970.
    PubMed     Text format     Abstract available


  373. SUPINDHAM T, Chariyalertsak S, Utaipat U, Miura T, et al
    High Prevalence and Genotype Diversity of Anal HPV Infection among MSM in Northern Thailand.
    PLoS One. 2015;10:e0124499.
    PubMed     Text format     Abstract available


  374. DOMENECH M, Damian D, Ardanuy C, Linares J, et al
    Emerging, Non-PCV13 Serotypes 11A and 35B of Streptococcus pneumoniae Show High Potential for Biofilm Formation In Vitro.
    PLoS One. 2015;10:e0125636.
    PubMed     Text format     Abstract available


  375. DENG L, Ibanez LI, Van den Bossche V, Roose K, et al
    Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages.
    PLoS One. 2015;10:e0126650.
    PubMed     Text format     Abstract available


  376. LIU S, Sun W, Chu J, Huang X, et al
    Construction of Recombinant HVT Expressing PmpD, and Immunological Evaluation against Chlamydia psittaci and Marek's Disease Virus.
    PLoS One. 2015;10:e0124992.
    PubMed     Text format     Abstract available


  377. REGUZOVA A, Antonets D, Karpenko L, Ilyichev A, et al
    Design and Evaluation of Optimized Artificial HIV-1 Poly-T Cell-Epitope Immunogens.
    PLoS One. 2015;10:e0116412.
    PubMed     Text format     Abstract available


  378. BOTTAZZI B, Santini L, Savino S, Giuliani MM, et al
    Recognition of Neisseria meningitidis by the long pentraxin PTX3 and its role as an endogenous adjuvant.
    PLoS One. 2015;10:e0120807.
    PubMed     Text format     Abstract available


  379. ATALLA H, Lysnyansky I, Raviv Y, Rottem S, et al
    Mycoplasma gallisepticum inactivated by targeting the hydrophobic domain of the membrane preserves surface lipoproteins and induces a strong immune response.
    PLoS One. 2015;10:e0120462.
    PubMed     Text format     Abstract available


  380. KUO CF, Tsao N, Cheng MH, Yang HC, et al
    Application of the C3-binding motif of streptococcal pyrogenic exotoxin B to protect mice from invasive group a streptococcal infection.
    PLoS One. 2015;10:e0117268.
    PubMed     Text format     Abstract available


  381. SCHMEISSER F, Vasudevan A, Verma S, Wang W, et al
    Antibodies to Antigenic Site A of Influenza H7 Hemagglutinin Provide Protection against H7N9 Challenge.
    PLoS One. 2015;10:e0117108.
    PubMed     Text format     Abstract available


  382. LOOKER KJ, Magaret AS, Turner KM, Vickerman P, et al
    Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012.
    PLoS One. 2015;10:e114989.
    PubMed     Text format     Abstract available


  383. ZHANG C, Zhu S, Wei L, Yan X, et al
    Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein Promotes Protective Immune Responses in Mice.
    PLoS One. 2015;10:e0129617.
    PubMed     Text format     Abstract available


  384. DIA N, Fall A, Ka R, Fall A, et al
    Epidemiology and genetic characterization of measles strains in Senegal, 2004-2013.
    PLoS One. 2015;10:e0121704.
    PubMed     Text format     Abstract available


  385. WANG J, Hilchey SP, Hyrien O, Huertas N, et al
    Multi-Dimensional Measurement of Antibody-Mediated Heterosubtypic Immunity to Influenza.
    PLoS One. 2015;10:e0129858.
    PubMed     Text format     Abstract available


  386. VASSELL R, He Y, Vennakalanti P, Dey AK, et al
    Immunogens Modeling a Fusion-Intermediate Conformation of gp41 Elicit Antibodies to the Membrane Proximal External Region of the HIV Envelope Glycoprotein.
    PLoS One. 2015;10:e0128562.
    PubMed     Text format     Abstract available


  387. HUANG AS, Chen WC, Huang WT, Huang ST, et al
    Public Health Responses to Reemergence of Animal Rabies, Taiwan, July 16-December 28, 2013.
    PLoS One. 2015;10:e0132160.
    PubMed     Text format     Abstract available


  388. JIMENEZ-TRUJILLO I, Jimenez-Garcia R, Esteban-Hernandez J, Hernandez-Barrera V, et al
    Predictors of Adherence to Multiple Clinical Preventive Recommendations among Adults with Diabetes in Spain.
    PLoS One. 2015;10:e0131844.
    PubMed     Text format     Abstract available


  389. MA M, Anderson BD, Wang T, Chen Y, et al
    Serological Evidence and Risk Factors for Swine Influenza Infections among Chinese Swine Workers in Guangdong Province.
    PLoS One. 2015;10:e0128479.
    PubMed     Text format     Abstract available


  390. BOSTROM MM, Irjala H, Mirtti T, Taimen P, et al
    Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer.
    PLoS One. 2015;10:e0133552.
    PubMed     Text format     Abstract available


  391. PREVATO M, Ferlenghi I, Bonci A, Uematsu Y, et al
    Expression and Characterization of Recombinant, Tetrameric and Enzymatically Active Influenza Neuraminidase for the Setup of an Enzyme-Linked Lectin-Based Assay.
    PLoS One. 2015;10:e0135474.
    PubMed     Text format     Abstract available


  392. DENG K, Liu R, Rao H, Jiang D, et al
    Antibodies Targeting Novel Neutralizing Epitopes of Hepatitis C Virus Glycoprotein Preclude Genotype 2 Virus Infection.
    PLoS One. 2015;10:e0138756.
    PubMed     Text format     Abstract available


  393. CHOI SJ, Kim MH, Jeon J, Kim OY, et al
    Active Immunization with Extracellular Vesicles Derived from Staphylococcus aureus Effectively Protects against Staphylococcal Lung Infections, Mainly via Th1 Cell-Mediated Immunity.
    PLoS One. 2015;10:e0136021.
    PubMed     Text format     Abstract available


  394. VAN DIJK CE, Hooiveld M, Jentink A, Isken LD, et al
    Experiences of General Practitioners and Practice Assistants during the Influenza A(H1N1) Pandemic in the Netherlands: A Cross-Sectional Survey.
    PLoS One. 2015;10:e0135666.
    PubMed     Text format     Abstract available


  395. POTEET E, Lewis P, Li F, Zhang S, et al
    A Novel Prime and Boost Regimen of HIV Virus-Like Particles with TLR4 Adjuvant MPLA Induces Th1 Oriented Immune Responses against HIV.
    PLoS One. 2015;10:e0136862.
    PubMed     Text format     Abstract available


  396. BILLINGS E, Sanders-Buell E, Bose M, Bradfield A, et al
    The Number and Complexity of Pure and Recombinant HIV-1 Strains Observed within Incident Infections during the HIV and Malaria Cohort Study Conducted in Kericho, Kenya, from 2003 to 2006.
    PLoS One. 2015;10:e0135124.
    PubMed     Text format     Abstract available


  397. JEYANATHAN M, Shao Z, Yu X, Harkness R, et al
    AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates.
    PLoS One. 2015;10:e0135009.
    PubMed     Text format     Abstract available


  398. TEWAWONG N, Prachayangprecha S, Vichiwattana P, Korkong S, et al
    Assessing Antigenic Drift of Seasonal Influenza A(H3N2) and A(H1N1)pdm09 Viruses.
    PLoS One. 2015;10:e0139958.
    PubMed     Text format     Abstract available


  399. ADETIFA IM, Muhammad AK, Jeffries D, Donkor S, et al
    A Tuberculin Skin Test Survey and the Annual Risk of Mycobacterium tuberculosis Infection in Gambian School Children.
    PLoS One. 2015;10:e0139354.
    PubMed     Text format     Abstract available


  400. JONES-LOPEZ EC, White LF, Kirenga B, Mumbowa F, et al
    Cough Aerosol Cultures of Mycobacterium tuberculosis: Insights on TST / IGRA Discordance and Transmission Dynamics.
    PLoS One. 2015;10:e0138358.
    PubMed     Text format     Abstract available


  401. CHA SB, Kim WS, Kim JS, Kim H, et al
    Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
    PLoS One. 2015;10:e0141577.
    PubMed     Text format     Abstract available


  402. LEE YN, Kim MC, Lee YT, Hwang HS, et al
    Cross Protection against Influenza A Virus by Yeast-Expressed Heterologous Tandem Repeat M2 Extracellular Proteins.
    PLoS One. 2015;10:e0137822.
    PubMed     Text format     Abstract available


  403. OZEKI Y, Igarashi M, Doe M, Tamaru A, et al
    A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Gueren.
    PLoS One. 2015;10:e0141658.
    PubMed     Text format     Abstract available


  404. WANG PC, Mwango A, Moberley S, Brockman BJ, et al
    A Cluster Randomised Trial on the Impact of Integrating Early Infant HIV Diagnosis with the Expanded Programme on Immunization on Immunization and HIV Testing Rates in Rural Health Facilities in Southern Zambia.
    PLoS One. 2015;10:e0141455.
    PubMed     Text format     Abstract available


  405. BADAMCHI-ZADEH A, McKay PF, Holland MJ, Paes W, et al
    Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies.
    PLoS One. 2015;10:e0141209.
    PubMed     Text format     Abstract available


  406. WEBBY RJ, Weaver EA
    Centralized Consensus Hemagglutinin Genes Induce Protective Immunity against H1, H3 and H5 Influenza Viruses.
    PLoS One. 2015;10:e0140702.
    PubMed     Text format     Abstract available


    January 2014
  407. TASSANEETRITHEP B, Tivon D, Swetnam J, Karasavvas N, et al
    Cryptic Determinant of alpha4beta7 Binding in the V2 Loop of HIV-1 gp120.
    PLoS One. 2014;9:e108446.
    PubMed     Text format     Abstract available


  408. SKRASTINA D, Petrovskis I, Lieknina I, Bogans J, et al
    Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.
    PLoS One. 2014;9:e114006.
    PubMed     Text format     Abstract available


  409. SICURELLA M, Nicoli F, Gallerani E, Volpi I, et al
    An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge.
    PLoS One. 2014;9:e100844.
    PubMed     Text format     Abstract available


  410. BILCKE J, Coenen S, Beutels P
    Influenza-Like-Illness and Clinically Diagnosed Flu: Disease Burden, Costs and Quality of Life for Patients Seeking Ambulatory Care or No Professional Care at All.
    PLoS One. 2014;9:e102634.
    PubMed     Text format     Abstract available


  411. KREBS SJ, McBurney SP, Kovarik DN, Waddell CD, et al
    Multimeric Scaffolds Displaying the HIV-1 Envelope MPER Induce MPER-Specific Antibodies and Cross-Neutralizing Antibodies when Co-Immunized with gp160 DNA.
    PLoS One. 2014;9:e113463.
    PubMed     Text format     Abstract available


  412. JALAH R, Kulkarni V, Patel V, Rosati M, et al
    DNA and protein co-immunization improves the magnitude and longevity of humoral immune responses in macaques.
    PLoS One. 2014;9:e91550.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: